ToughBuilt Industries (TBLT) 10-Q 6 Nov 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Nov. 06, 2020
Cover [Abstract]
Entity Registrant Name	Toughbuilt Industries, Inc
Entity Central Index Key	0001668370
Document Type	10-Q
Document Period End Date	Sep. 30, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	true
Entity Ex transition period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		38,414,631
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2020

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current Assets
Cash	$ 8,891,612	$ 25,063
Accounts receivable	12,584,296	2,075,380
Factor receivables, net	2,107,082	174,042
Inventory	6,684,030	2,215,497
Prepaid assets	1,045,210	254,070
Note receivable	1,480,000	4,480,000
Total Current Assets	32,792,230	9,224,052
Other Assets
Property and equipment, net	2,352,561	1,029,885
Other assets	221,168	215,688
Total Assets	35,365,959	10,469,625
Current Liabilities
Accounts payable	5,508,639	2,536,871
Accrued expenses	548,066	364,309
Factor loan payable	1,513,885	125,645
Convertible notes payable, net of discount	1,945,065	4,216,307
Total Current Liabilities	9,515,655	7,243,132
Total Liabilities	9,515,655	7,243,132
Commitment and Contingencies (Note 5)
Shareholders' Equity
Common stock, $0.0001 par value, 200,000,000 shares authorized, 38,414,631 and 3,300,015 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively	3,842	330
Additional paid-in capital	75,412,814	41,823,048
Accumulated deficit	(49,566,352)	(43,413,370)
Total Shareholders' Equity	25,850,304	3,226,493
Total Liabilities and Shareholders' Equity	35,365,959	10,469,625
Series D Preferred Stock [Member]
Shareholders' Equity
Preferred Stock value
Total Shareholders' Equity		4,816,485
Series D Preferred Stock [Member]
Shareholders' Equity
Preferred Stock value		$ 4,816,485

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Common stock par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	38,414,631	3,300,015
Common stock, shares outstanding	38,414,631	3,300,015
Series D Preferred Stock [Member]
Preferred Stock par value	$ 1,000	$ 1,000
Preferred Stock, shares authorized	5,775	5,775
Preferred Stock, shares issued	0	5,775
Preferred Stock, shares outstanding	0	5,775
Preferred Stock, liquidation preference		$ 5,775,000

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenues, net of allowances
Total revenues, net of allowances	$ 16,663,389	$ 4,784,087	$ 27,412,547	$ 14,560,898
Cost of Goods Sold
Total cost of goods sold	9,114,092	3,304,118	15,784,464	10,726,293
Gross profit	7,549,297	1,479,969	11,628,083	3,834,605
Operating expenses:
Selling, general and administrative expenses	6,423,593	3,549,480	15,480,432	8,807,483
Research and development	789,890	391,460	1,496,129	1,521,503
Total operating expenses	7,213,483	3,940,940	16,976,561	10,328,986
Income (loss) from operations	335,814	(2,460,971)	(5,348,478)	(6,494,381)
Other income (expense)
Interest expense	(214,979)	(288,152)	(804,504)	(456,689)
Change in fair value of warrant derivative		59,781		4,769,363
Total other income (expense)	(214,979)	(228,371)	(804,504)	4,312,674
Net income (loss)	120,835	(2,689,342)	(6,152,982)	(2,181,707)
Redemption of Series D Preferred Stock deemed dividend			(1,295,294)
Common stock deemed dividend				(2,137,190)
Net income (loss) attributable to common stockholders	$ 120,835	$ (2,689,342)	$ (7,488,276)	$ (4,318,897)
Basic and diluted net loss per share attributed to common stockholders
Basic net loss per common share	$ 0	$ (0.87)	$ (0.32)	$ (2.27)
Basic weighted average common shares outstanding	38,414,631	3,084,456	23,154,481	1,906,179
Diluted net loss per common share	$ 0	$ (0.87)	$ (0.32)	$ (2.27)
Diluted weighted average common shares outstanding	38,414,631	3,084,456	23,154,481	1,906,179
Metal Goods [Member]
Revenues, net of allowances
Total revenues, net of allowances	$ 5,368,015	$ 2,527,734	$ 10,824,861	$ 6,443,984
Cost of Goods Sold
Total cost of goods sold	2,906,559	1,759,091	6,559,020	4,733,524
Soft Goods [Member]
Revenues, net of allowances
Total revenues, net of allowances	11,295,374	2,256,353	16,587,686	8,116,914
Cost of Goods Sold
Total cost of goods sold	$ 6,207,533	$ 1,545,027	$ 9,225,444	$ 5,992,769

Statements of Changes in Stockh

Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Series C Preferred Stock [Member]	Series D Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2018			$ 99	$ 20,152,995	$ (39,112,401)	$ (18,959,307)
Balance, shares at Dec. 31, 2018			987,087
Issuance of common stock upon exercise of Series A Warrants, net of cost			$ 4	2,172,676		2,172,680
Issuance of common stock upon exercise of Series A Warrants, net of cost, shares			42,412
Issuance of common stock as inducement to exercise Series A Warrants			$ 5	(5)		0
Issuance of common stock as inducement to exercise Series A Warrants, shares			50,894
Issuance of common stock upon exercise of Series B warrants			$ 36	5,635,733		5,635,769
Issuance of common stock upon exercise of Series B warrants, shares			362,905
Issuance of common stock upon exercise of Placement Agent Warrants				16,818		16,818
Issuance of common stock upon exercise of Placement Agent Warrants, shares			400
Stock based compensation expense				105,642		105,642
Net income loss					500,213	500,213
Balance at Mar. 31, 2019			$ 144	28,083,859	(38,612,188)	(10,528,185)
Balance, shares at Mar. 31, 2019			1,443,698
Balance at Dec. 31, 2018			$ 99	20,152,995	(39,112,401)	(18,959,307)
Balance, shares at Dec. 31, 2018			987,087
Net income loss						(2,181,707)
Balance at Sep. 30, 2019			$ 279	41,465,908	(41,294,108)	172,079
Balance, shares at Sep. 30, 2019	4,268		2,800,015
Balance at Mar. 31, 2019			$ 144	28,083,859	(38,612,188)	(10,528,185)
Balance, shares at Mar. 31, 2019			1,443,698
Issuance of common stock upon exercise of Series B warrants			$ 87	7,733,376		7,733,463
Issuance of common stock upon exercise of Series B warrants, shares			874,995
Issuance of Series C preferred stock upon exchange of Series A and Series B warrants				3,671,024		3,671,024
Issuance of Series C preferred stock upon exchange of Series A and Series B warrants, shares	4,268
Stock based compensation expense				104,121		104,121
Net income loss					7,422	7,422
Balance at Jun. 30, 2019			$ 231	39,592,380	(38,604,766)	987,845
Balance, shares at Jun. 30, 2019	4,268		2,318,693
Issuance of common stock upon exercise of Series B warrants			$ 38	1,215,101		1,215,139
Issuance of common stock upon exercise of Series B warrants, shares			381,322
Issuance of common stock upon Series C preferred conversion			$ 10	(10)
Issuance of common stock upon Series C preferred conversion, shares			100,000
Stock based compensation expense				63,437		63,437
Warrants issued in connection with convertible notes payable				595,000		595,000
Net income loss					(2,689,342)	(2,689,342)
Balance at Sep. 30, 2019			$ 279	41,465,908	(41,294,108)	172,079
Balance, shares at Sep. 30, 2019	4,268		2,800,015
Balance at Dec. 31, 2019		$ 4,816,485	$ 330	41,823,048	(43,413,370)	3,226,493
Balance, shares at Dec. 31, 2019	1,268	5,775	3,300,015
Redemption of Series D Preferred Stock		$ (1,844,860)		(1,295,294)		(3,140,154)
Redemption of Series D Preferred Stock, shares		(2,212)
Issuance of common stock upon Series C preferred conversion			$ 13	(13)
Issuance of common stock upon Series C preferred conversion, shares	(1,268)		126,800
Issuance of common stock upon conversion of convertible note payable			$ 20	(186,171)		(186,151)
Issuance of common stock upon conversion of convertible note payable, shares			200,000
Issuance of common stock and warrants, net of issuance costs			$ 495	9,388,245		9,388,740
Issuance of common stock and warrants, net of issuance costs, shares			4,945,000
Issuance of common stock upon exercise of warrants			$ 241	(241)
Issuance of common stock upon exercise of warrants, shares			2,407,953
Stock based compensation expense				96,490		96,490
Net income loss					(3,754,659)	(3,754,659)
Balance at Mar. 31, 2020		$ 2,971,625	$ 1,099	49,826,064	(47,168,029)	5,630,759
Balance, shares at Mar. 31, 2020		3,563	10,979,768
Balance at Dec. 31, 2019		$ 4,816,485	$ 330	41,823,048	(43,413,370)	3,226,493
Balance, shares at Dec. 31, 2019	1,268	5,775	3,300,015
Net income loss						(6,152,982)
Balance at Sep. 30, 2020			$ 3,842	75,412,814	(49,566,352)	25,850,304
Balance, shares at Sep. 30, 2020			38,414,631
Balance at Mar. 31, 2020		$ 2,971,625	$ 1,099	49,826,064	(47,168,029)	5,630,759
Balance, shares at Mar. 31, 2020		3,563	10,979,768
Issuance of common stock upon conversion of convertible note payable			$ 320	3,091,965		3,092,285
Issuance of common stock upon conversion of convertible note payable, shares			3,200,000
Issuance of common stock and warrants, net of issuance costs			$ 2,070	18,731,930		18,734,000
Issuance of common stock and warrants, net of issuance costs, shares			20,700,000
Issuance of common stock upon exercise of warrants			$ 3	(3)
Issuance of common stock upon exercise of warrants, shares			33,437
Issuance of common stock upon conversion of Series D Preferred Stock		$ (2,971,625)	$ 314	2,971,311
Issuance of common stock upon conversion of Series D Preferred, shares		(3,563)	3,141,426
Issuance of common stock for services			$ 36	572,364		572,400
Issuance of common stock for services, shares			360,000
Stock based compensation expense				227,499		227,499
Net income loss					(2,519,158)	(2,519,158)
Balance at Jun. 30, 2020			$ 3,842	75,421,130	(49,687,187)	25,737,785
Balance, shares at Jun. 30, 2020			38,414,631
Stock based compensation expense				(8,316)		(8,316)
Net income loss					120,835	120,835
Balance at Sep. 30, 2020			$ 3,842	$ 75,412,814	$ (49,566,352)	$ 25,850,304
Balance, shares at Sep. 30, 2020			38,414,631

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income (loss)	$ (6,152,982)	$ (2,181,707)
Adjustments to reconcile from net income (loss) to net cash used in operating activities:
Depreciation	394,322	157,652
Amortization of debt discount and debt issuance cost	634,892	198,913
Change in fair value of warrant derivative		(4,769,363)
Stock-based compensation expense	315,673	273,200
Changes in operating assets and liabilities
Accounts receivable, net	(10,508,916)	(689,042)
Factor receivables, net	(1,933,040)	597,871
Inventory	(4,468,533)	(1,394,524)
Prepaid assets	(218,739)	7,486
Other assets	(5,479)	(66,415)
Accounts payable	2,971,766	82,119
Accrued expenses	183,757	(541,834)
Deferred revenue		(107,776)
Net cash used in operating activities	(18,787,279)	(8,433,420)
Cash flows from investing activities:
Proceeds from note receivable	3,000,000
Purchases of property and equipment	(1,716,998)	(651,795)
Net cash provided by (used in) investing activities	1,283,002	(651,795)
Cash flows from financing activities:
Proceeds from sales of common stock and warrants, net of costs	28,122,740
Proceeds from exercise of Series A warrants		2,172,680
Proceeds from exercise of Placement Agent warrants		16,818
Proceeds from note payable		4,515,000
Proceeds from factor loan payable	1,388,240
Repayments of factor loan payable		(623,844)
Repayments of Series D Preferred Stock	(3,140,154)
Net cash provided by financing activities	26,370,826	6,080,654
Net increase (decrease) increase in cash	8,866,549	(3,004,561)
Cash, beginning of period	25,063	5,459,884
Cash, end of period	8,891,612	2,455,323
Supplemental disclosure of cash flow information:
Interest
Income taxes		800
Supplemental disclosure of non-cash investing and financing activities:
Cashless exercise of warrants	244
Issuance of warrants in connection with convertible notes payable		575,000
Debt issuance cost paid with warrants		20,000
Conversion of Series C Preferred Stock to common stock	13	3,671,024
Conversion of convertible notes payable to common stock	2,906,134
Conversation of Series D Preferred Stock to common stock	2,971,311
Issuance of common stock for prepaid services	572,400
Restricted promissory note in connection with convertible notes payable		4,780,000
Original issue discount		1,720,000
Conversion of Series B warrants into common stock		$ 14,584,371

Nature of Operations and Basis

Nature of Operations and Basis of Presentation	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations and Basis of Presentation	NOTE 1: NATURE OF OPERATIONS AND BASIS OF PRESENTATION General The unaudited condensed financial statements of ToughBuilt Industries, Inc. (“ToughBuilt” or the “Company”) as of September 30, 2020 and for the three and nine months ended September 30, 2020 and 2019 should be read in conjunction with the financial statements for the year ended December 31, 2019 included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, which was filed with the Securities Exchange Commission (“SEC”) on March 30, 2020 and can also be found on the Company’s website (www.toughbuilt.com). ToughBuilt was incorporated under the laws of the State of Nevada on April 9, 2012 under the name Phalanx, Inc., and on December 29, 2015, Phalanx, Inc. changed its name to ToughBuilt Industries, Inc. On April 15, 2020, the Company effected a 1-for-10 reverse stock split (the “Reverse Split”) of its issued and outstanding common stock. As a result of the Reverse Split, each ten shares of issued and outstanding prior to the Reverse Split were converted into one share of common stock. All share and per share numbers in the unaudited condensed financial statements and notes below have been revised retroactively to reflect the Reverse Split. Nature of Operations In these notes, the terms “we”, “our”, “ours”, “us”, “it”, “its”, “ToughBuilt”, and the “Company” refer to ToughBuilt Industries, Inc. The Company designs and distributes tools and accessories to the home improvement community and the building industry. The Company aspires to augment brand loyalty in part from the enlightened creativity of its end users throughout the global tool market industry. The Company holds exclusive patents and licenses to develop, manufacture, market and distribute various home improvement and construction product lines for both Do-it-Yourself (“DIY”) and professional trade markets under the TOUGHBUILT® brand name. TOUGHBUILT distributes products in the following categories, all designed and engineered in the United States and manufactured by third party vendors in China, with manufacturing being brought online in India and the Philippines: ● tool belts, tool bags and other personal tool organizer products; ● complete line of knee pads for various construction applications; and ● job-site tools and material support products consisting of a full line of miter-saws and table saw stands, saw horses/job site tables and roller stands. On February 24, 2020, the Company closed on the public offering of 0.445 million shares of its common stock, for gross proceeds of $912,250 based upon the overallotment option arising from the closing of its January 28, 2020 public offering. In the January 28, 2020 public offering, the Company sold 4.5 million shares of its common stock and 49.45 million warrants (each exercisable into 1/20 of a share of common stock for a total of 2.4725 million shares of common stock) from which it received gross proceeds of $9,472,250. On June 12, 2020, the Company closed on the public offering of 1.7 million shares of its common stock, for gross proceeds of $1,683,000 based upon the overallotment option arising from the closing of its June 2, 2020 public offering. In the June 2, 2020 public offering, the Company sold 19 million shares of its common stock and 20.7 million warrants from which it received gross proceeds of $19,017,000. Risk and Uncertainty Concerning Covid-19 In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a pandemic which continues to spread throughout the United States and the World. We are currently monitoring the outbreak of COVID-19 and the related business and travel restrictions and changes to behavior intended to reduce its spread. All of our Chinese facilities were temporarily closed for a period of time. Most of these facilities have been reopened. Depending on the progression of the outbreak, our ability to obtain necessary supplies and ship finished products to customers may be partly or completely disrupted globally. Also, our ability to maintain appropriate labor levels could be disrupted. If the coronavirus continues to progress, it could have a material negative impact on our results of operations and cash flow, in addition to the impact on its employees. We have concluded that while it is reasonably possible that the virus could have a negative impact on the results of operations, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Liquidity As of September 30, 2020, the Company’s principal sources of liquidity consisted of approximately $8.9 million of cash and future cash generated from operations. The Company believes its current cash balances coupled with anticipated cash flow from operating activities will be sufficient to meet its working capital requirements for at least one year from the date of the issuance of the accompanying financial statements. The Company continues to control its cash expenses as a percentage of expected revenue on an annual basis and thus may use its cash balances in the short-term to invest in revenue growth. Based on current internal projections, the Company believes it has and/or will generate sufficient cash for its operational needs, including any required debt payments, for at least one year from the date of issuance of the accompanying financial statements. Management is focused on growing the Company’s existing product offering, as well as its customer base, to increase its revenues. The Company cannot give assurance that it can increase its cash balances or limit its cash consumption and thus maintain sufficient cash balances for its planned operations or future acquisitions. Future business demands may lead to cash utilization at levels greater than recently experienced. The Company may need to raise additional capital in the future. However, the Company cannot assure that it will be able to raise additional capital on acceptable terms, or at all. Subject to the foregoing, management believes that the Company has sufficient capital and liquidity to fund its operations for at least one year from the date of issuance of the accompanying financial statements. Basis of Presentation These interim condensed financial statements are unaudited and were prepared by the Company in accordance with generally accepted accounting principles in the United States of America (GAAP) and with the SEC’s instructions to Form 10-Q and Article 10 of Regulation S-X. The preparation of interim condensed financial statements requires management to make assumptions and estimates that impact the amounts reported. These interim condensed financial statements, reflect all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of the Company’s results of operations, financial position and cash flows for the interim periods ended September 30, 2020 and 2019; however, certain information and footnote disclosures normally included in our audited annual financial statements, as included in the Company’s interim condensed financial statements on Form 10-Q, have been condensed or omitted pursuant to such SEC rules and regulations and accounting principles applicable for interim periods. It is important to note that the Company’s results of operations and cash flows for interim periods are not necessarily indicative of the results of operations and cash flows to be expected for a full fiscal year or any other interim period. The information included in this Quarterly Report on Form 10-Q should be read in connection with the financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Use of Estimates The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts and factored receivables, valuation of long-lived assets, accrued liabilities, notes payable and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Cash The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents. The Company did not have any cash equivalents at September 30, 2020 and December 31, 2019. Accounts Receivable Accounts receivable represent income earned from the sale of tools and accessories for which the Company has not yet received payment. Accounts receivable are recorded at the invoiced amount and adjusted for amounts management expects to collect from balances outstanding at period-end. The Company estimates the allowance for doubtful accounts based on an analysis of specific accounts and an assessment of the customer’s ability to pay, among other factors. At September 30, 2020 and December 31, 2019, no allowance for doubtful accounts was recorded. The Company accounts for the transfer of accounts receivable to a third party under a factoring type arrangement in accordance with Accounting Standards Codification (“ASC”) 860, “ Transfers and Servicing Inventory Inventory is valued at the lower of cost or net realizable value using the first-in, first-out method. The reported net value of inventory includes finished saleable products that will be sold or used in future periods. The Company reserves for obsolete and slow-moving inventory. At September 30, 2020 and 2019, there were no reserves for obsolete and slow-moving inventory. Property and Equipment Property and equipment are recorded at cost, less accumulated depreciation. The Company provides for depreciation on a straight-line basis over the estimated useful lives of the assets which range from three to seven years. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the related assets when they are placed into service. The Company evaluates property and equipment for impairment periodically to determine if changes in circumstances or the occurrence of events suggest the carrying value of the asset or asset group may not be recoverable. Maintenance and repairs are charged to operations as incurred. Expenditures which substantially increase the useful lives of the related assets are capitalized. Long-lived Assets In accordance with ASC 360, “ Property, Plant, and Equipment Fair Value of Financial Instruments and Fair Value Measurements The Company adheres to ASC 820, which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 applies to reported balances that are required or permitted to be measured at fair value under existing accounting pronouncements; accordingly, the standard does not require any new fair value measurements of reported balances. ASC 820 emphasizes that fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). ● Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access. ● Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves that are observable at commonly quoted intervals. ● Level 3 inputs are unobservable inputs for the asset or liability, which is typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. The Company had no instruments requiring such valuation as of September 30, 2020 and December 31, 2019. Revenue Recognition The Company recognizes revenues when product is delivered to the customer, and the ownership is transferred. The Company’s revenue recognition policy is based on the revenue recognition criteria established under the Financial Accounting Standards Board – Accounting Standards Codification 606 “Revenue From Contracts With Customers Income Taxes The Company accounts for income taxes following the asset and liability method in accordance with the ASC 740 “Income Taxes.” Under such method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. The Company applies the accounting guidance issued to address the accounting for uncertain tax positions. This guidance clarifies the accounting for income taxes, by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements as well as provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company classifies interest and penalty expense related to uncertain tax positions as a component of income tax expense. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years that the asset is expected to be recovered or the liability settled. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets depends on the generation of future taxable income during the period in which related temporary differences become deductible. The Company considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in its assessment of a valuation allowance. During 2020, the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) was passed, which temporarily removed 80% limitations on net operating loss carryforwards for the years 2019 and 2020. Stock Based Compensation The Company accounts for stock-based compensation in accordance with ASC 718-10, “ Share-Based Payment Compensation – Stock Compensation (Topic 718), Improvements to Nonemployee Share-Based Payment Accounting The Company estimates the fair value of stock options granted using the Black-Scholes option-pricing formula. This fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. The Company’s determination of fair value using an option-pricing model is affected by the stock price as well as assumptions regarding the number of highly subjective variables. The Company estimates volatility based upon the historical stock price of the comparable companies and estimates the expected term for employee stock options using the simplified method for employees and directors and the contractual term. The risk-free rate is determined based upon the prevailing rate of United States Treasury securities with similar maturities. The Company recognizes forfeitures as they occur rather than applying a prospective forfeiture rate in advance. Earnings (Loss) Per Share The Company computes net earnings (loss) per share in accordance with ASC 260, “ Earnings per Share” Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Net income (loss) computation of basic and diluted net loss per common share: Net income (loss) $ 120,835 $ (2,689,342 ) $ (6,152,982 ) $ (2,181,707 ) Less: Redemption of Series D Preferred Stock deemed dividend - - (1,295,294 ) - Less: Common stock deemed dividend (inducement cost) - - - (2,137,190 ) Net income (loss) attributable to common stockholders $ 120,835 $ (2,689,342 ) $ (7,448,276 ) $ (4,318,897 ) Basic and diluted net loss per share: Basic net income (loss) per common share $ 0.00 $ (0.87 ) $ (0.32 ) $ (2.27 ) Basic weighted average common shares outstanding 38,414,631 3,084,456 23,154,481 1,906,179 Diluted net income (loss) per common share $ 0.00 $ (0.87 ) $ (0.32 ) $ (2.27 ) Diluted weighted average common shares outstanding 38,414,631 3,084,456 23,154,481 1,906,179 Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows as of September 30, (in common equivalent shares): 2020 2019 Warrants 21,925,102 1,183,877 Series A & B Notes 213,105 - Options and restricted stock units 197,193 106,538 Total anti-dilutive weighted average shares 22,335,400 1,290,415 No Segment Reporting The Company operates one reportable segment referred to as the tools segment. A single management team that reports to the Chief Executive Officer comprehensively manages the business. Accordingly, the Company does not have separately reportable segments. Recent Accounting Pronouncements As an emerging growth company, the Company has elected to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Securities and Exchange Act of 1934, as amended. In February 2016, the FASB issued ASU 2016-02, “ Leases In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (“Topic 326”)”. The ASU introduces a new accounting model, the Current Expected Credit Losses model (“CECL”), which requires earlier recognition of credit losses and additional disclosures related to credit risk. The CECL model utilizes a lifetime expected credit loss measurement objective for the recognition of credit losses at the time the financial asset is originated or acquired. ASU 2016-13 is effective for annual period beginning after December 15, 2022, including interim reporting periods within those annual reporting periods. The Company is currently evaluating this guidance to determine its impact it may have on its financial statements. In December 2019, the FASB Issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting of Income Taxes,” which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for fiscal years and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating this guidance to determine its impact it may have on its financial statements. In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and simplifies the diluted earnings per share calculation in certain areas. The amendments in this ASU are effective for annual and interim periods beginning after December 15, 2021, although early adoption is permitted. The Company is in the process of evaluating the impact of this new guidance on its financial statements.

Factor Receivables, Letters of

Factor Receivables, Letters of Credit Payable and Loan Payable	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Factor Receivables, Letters of Credit Payable and Loan Payable	NOTE 3: FACTOR RECEIVABLES, LETTERS OF CREDIT PAYABLE AND LOAN PAYABLE In April 2013, the Company entered into a financing arrangement with a third-party purchase order financing company (the “Factor”), whereby the Company assigned to the Factor selected sales orders from its customers in exchange for opening a letter of credit (“LC”) with its vendors to manufacture its products. The Company paid an initial fixed fee of 5% of the cost of products it purchased from the vendor upon opening the LC, and 1% each 30 days thereafter, after the LC is funded by the Factor until such time as the Factor receives the payment from the Company’s customers. The factoring agreement provides for full recourse against the Company for factored accounts receivable that are not collected by the Factor for any reason, and the collection of such accounts receivable is fully secured by substantially all of the receivables of the Company. The factoring advances for the LCs at September 30, 2020 and December 31, 2019 have been treated as a loan payable to third party in the accompanying balance sheets, and total outstanding accounts receivable factored, net of allowance for sales returns, discounts and rebates of $13,000 as of September 30, 2020 and December 31, 2019, were $2,107,082 and $174,102, respectively.

Property and Equipment, Net

Property and Equipment, Net	9 Months Ended
	Sep. 30, 2020
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	NOTE 4: PROPERTY AND EQUIPMENT, NET Property and equipment consists of the following: September 30, 2020 December 31, 2019 Furniture $ 183,512 $ 111,490 Computers 460,500 254,243 Production equipment 182,446 182,446 Automobile and transportation 412,509 - Tooling and molds 1,515,400 605,485 Website design 477,238 360,943 Leasehold Improvements 42,249 42,249 Less: accumulated depreciation (921,293 ) (526,971 ) Property and Equipment, net $ 2,352,561 $ 1,029,885 Depreciation and capitalized costs with respect thereto consists of the following: Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Depreciation expense $ 176,691 $ 55,741 $ 394,322 $ 157,652

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 5 – COMMITMENTS AND CONTINGENCIES On January 3, 2017, the Company executed a non-cancellable operating lease for its principal office with the lease commencing February 1, 2017 for a five (5) year term. The Company paid a security deposit of $29,297. The lease required the Company to pay its proportionate share of direct costs estimated to be 22.54% of the total property, a fixed monthly direct cost of $6,201 for each month during the term of the lease, and monthly rental pursuant to the lease terms. The Company entered into a lease for office space at 8669 Research Drive, in Irvine, CA, which is to replace the current corporate headquarters. The lease commenced on December 1, 2019 with no rent due until April 1, 2020. From April 1, 2020 through March 31, 2025, base rent will be due on the first of each month in the amount of $25,200 escalating annually on December 1 of each year to $29,480 beginning December 1, 2023. The Company paid an initial amount of $68,128 comprising the rent for April 2020, a security deposit and the amount due for property taxes, insurance and association fees. On August 30, 2018, the Company entered into an agreement with a customer to pay a slotting allowance of $1,000,000 payable in three annual installments of $333,334 on March 1, 2019, $333,333 on March 1, 2020 and $333,333 on March 1, 2021. Future minimum lease and other commitments of the Company are as follows: For the years ending Slotting Expenses Building leases Total 2020 (remaining) - 121,984 121,984 2021 333,333 502,872 836,205 2022 - 371,077 371,077 2023 - 341,653 341,653 2024 - 358,085 358,085 Thereafter - 89,521 89,521 $ 333,333 $ 1,785,192 $ 2,118,525 The Company recorded rent expense of $208,672 and $50,110 and $536,566 and $133,762 for the three and nine months ended September 30, 2020 and 2019, respectively. The Company recorded a slotting expense of $83,334 and $83,334 and $250,002 and $250,002 for the three and nine months ended September 30, 2020 and 2019, respectively. Employment Agreements with Officers On January 3, 2017, the Company entered into an employment agreement with its President and Chief Executive Officer for a five-year term. The officer received a sign-on-bonus of $50,000 and was entitled to an annual base salary of $350,000 to increase by 10% each year commencing on January 1, 2018. The officer was also granted a stock option to purchase 125,000 shares of the Company’s common stock at an exercise price of $10.00 per share. On January 3, 2017, the Company entered into an employment agreement with its Vice-President of Design and Development for a five-year term. Under the terms of this agreement, the officer received a sign-on-bonus of $35,000 and is entitled to an annual base salary of $250,000 beginning on December 1, 2016 to increase by 10% each year commencing on January 1, 2018. On January 3, 2017, the Company entered into an employment agreement with its Chief Operating Officer and Secretary for a three-year term. Under the terms of this agreement, the officer is entitled to an annual base salary of $180,000 beginning on January 1, 2017 to increase by 10% each year commencing on January 1, 2018. The Company’s former Chief Financial Officer was appointed on June 14, 2019, with whom the Company entered into a verbal consulting arrangement at $10,000 per month. Effective July 2, 2020 such former Chief Financial Officer resigned from the Company. Effective July 1, 2020, the Company and the interim Chief Financial Officer have agreed to a salary of $230,000 per annum. The employment agreements also entitle the officers to receive, among other benefits, the following compensation: (i) eligibility to receive an annual cash bonus at the sole discretion of the Board and as determined by the Compensation Committee commensurate with the policies and practices applicable to other senior executive officers of the Company; (ii) an opportunity to participate in any stock option, performance share, performance unit or other equity based long-term incentive compensation plan commensurate with the terms and conditions applicable to other senior executive officers and (iii) participation in benefit plans, practices, policies and programs provided by the Company (including, without limitation, medical, prescription, dental, disability, employee life, group life, accidental death and travel accident insurance plans and programs) to the extent available to the Company’s other senior executive officers. Litigation Costs and Contingencies From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business. Other than as set forth below, management is currently not aware of any such legal proceedings or claims that could have, individually or in the aggregate, a material adverse effect on our business, financial condition, or operating results. Edwin Minassian v. Michael Panosian and Toughbuilt Industries, Inc., Los Angeles Superior Court Case No. EC065533. On August 16, 2016, Plaintiff Edwin Minassian filed a complaint against Defendants ToughBuilt Industries, Inc. (the “Company”) and Michael Panosian in the Superior Court of California, County of Los Angeles, Case No. EC065533. The complaint alleges breach of oral contracts to pay Plaintiff for consulting and finder’s fees, and to hire him as an employee. The complaint further alleged claims of fraud and misrepresentation relating to an alleged payment in exchange for stock in the Company. The complaint seeks unspecified monetary damages, declaratory relief, stock in the Company, and other relief according to proof. On April 12, 2018, the Court entered judgments of default against the Company and Mr. Panosian in the amounts of $7,080 and $235,542, plus awarding Mr. Minassian a 7% ownership interest in the Company (the “Judgments”). Mr. Minassian served notice of entry of the judgments on April 17, 2018 and the Company and Mr. Panosian received notice of the entry of the default judgments on April 19, 2018. The Company and Panosian satisfied the judgments on September 14, 2018 by payment of $252,949 to Plaintiff Minassian and by issuing Plaintiff Minassian 376,367 shares of common stock of the Company. On October 18, 2018, the Company and Panosian filed a Notice of Appeal from the Order denying their motion for relief from the above-referenced default judgment. On October 1, 2019, the Second Appellate District of the California Court of Appeal issued its opinion reversing the trial court’s order denying Toughbuilt’s motion for relief from the default judgment and directing the trial court to grant Toughbuilt’s motion for relief, including allowing Toughbuilt to file an Answer and contest Minassian’s claims. The appellate court recently issued a remittitur officially transferring the matter from the appellate court back to the trial court for further proceedings consistent with its ruling, and the Company and Panosian have filed an Answer to the Complaint. The trial court has not yet set a trial date, and discovery in this case is just now beginning. The Company intends to vigorously defend the Complaint and seek to recover the compensation and stock previously paid to satisfy the now vacated default judgment. The Company believes it has a strong position, but cannot quantify the likelihood that it will prevail in the above litigation, or any likely liability or recoveries, because of the current status of the case and the unpredictability of litigation. Minassian seeks damages and stock based on a breach of an alleged oral agreement. Discovery is presently ongoing. In addition, Plaintiff Minassaian is in violation of a court order for restitution and the Company is engaged in collection efforts to enforce that order. A trial date has been set for June 8, 2021. Design 1 st On November 26, 2019, Claimant Design 1 st The Company’s submission of its case brief outlining its claims and defense in full is due on December 11, 2020 . Design 1st’s submission is due on January 9, 2021. The parties have the option to take depositions after January 9, 2021. The arbitration hearing is scheduled for March 31-April 1, 2021. Design 1st is seeking $169,094.35 based on a claim for breach of contract for failure to pay, and the Company seeks $394,956.07 on its counter claim for breach of contract and fraud. The subject contract also contains an attorney’s fees clause providing that the prevailing party is entitled to recover attorney’s fees and costs, the precise amount of which will not be known until the prevailing party submits its attorney’s fees and costs during or following trial. The Company has recorded legal expense of $124,245 and $65,803 for the three months ended September 30, 2020 and 2019, respectively. The Company has recorded legal expense of $299,869 and $136,024 for the nine months ended September 30, 2020 and 2019, respectively. In the normal course of business, the Company incurs costs to hire and retain external legal counsel to advise it on regulatory, litigation and other matters. The Company expenses these costs as the related services are received. If a loss is considered and the amount can be reasonable estimated, the Company recognizes an expense for the estimated loss.

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Stockholders' Equity (Deficit)	NOTE 6: STOCKHOLDERS’ EQUITY (DEFICIT) At September 30, 2020 and December 31, 2019, the Company had 200,000,000 and 100,000,000 shares of common stock, respectively, and 5,000,000 shares of Series C preferred stock authorized, both with a par value of $0.0001 per share. In addition, as of September 30, 2020, the Company had 5,775 shares of Series D preferred stock, authorized, with a par value of $1,000 per share. Common Stock and Preferred Stock On January 24, 2019, the Company entered into an exchange agreement with two institutional investors pursuant to which these investors exercised Series A Warrants to purchase 424,116 shares of its common stock for cash proceeds of $2,172,680 to the Company, net of costs of $159,958. The two investors also exchanged Series A Warrants to purchase 508,940 shares of its common stock into 508,940 shares of its common stock and received new warrants to purchase an aggregate of 933,056 shares of its common stock. The Company recognized an inducement cost of $0 and $2,137,190 for the Series A Warrants conversion for the nine months ended September 30, 2020 and 2019, respectively, as an offset against stockholders’ equity. The inducement cost was calculated as being the difference between the fair value of equity instruments surrendered versus equity instruments issued pursuant to the terms of the exchange agreement. On February 14, 2019, the Company received cash proceeds of $16,818 from three placement agent warrant holders upon their exercise of 1,402 placement agent warrants to purchase 4,004 Class A Units, each Class A Unit consisting of one share of common stock and a Series A Warrant and a Series B Warrant (“Class A Unit”). Each Series A Warrant is exercisable by the holder thereof for one share of common stock at an exercise price of $36.70 for five years. The Series B Warrants have expired. On February 24, 2020, the Company closed on the public offering of 0.445 million shares of its common stock, for gross proceeds of $912,250 based upon the overallotment option arising from the closing of its January 28, 2020 public offering. In the January 28, 2020 public offering, the Company sold 4.5 million shares of its common stock and 49.45 million warrants (each exercisable into 1/20 of a share of common stock for a total of 2.4725 million shares of common stock) from which it received gross proceeds of $9,472,250. On June 12, 2020, the Company closed on the public offering of 1.7 million shares of its common stock, for gross proceeds of $1,683,000 based upon the overallotment option arising from the closing of its June 2, 2020 public offering. In the June 2, 2020 public offering, the Company sold 19 million shares of its common stock and 20.7 million warrants from which it received gross proceeds of $19,017,000. During the nine months ended September 30, 2020, 1,268 shares of Series C Preferred Stock converted into 126,800 shares of the Company’s common stock and 3,563 shares of Series D Preferred Stock converted into 3,141,426 shares of the Company’s common stock. During the nine months ended September 30, 2020, $3,200,000 principal amount of Notes was converted into the Company’s common Stock During 2020, the Company granted 360,000 shares of common stock to consultants in consideration for services rendered. As of September 30, 2020 and December 31, 2019, the Company had 38,414,631 and 3,300,015 shares of common stock issued and outstanding, respectively. Warrants Placement Agent Warrants The Company has issued an aggregate of 24,758 warrants to the placement agents to purchase one share of its common stock per warrant at an exercise price of $120 per share for 4,758 warrants and $10 for 20,000 warrants. The warrants issued in its October 2016 Private Placement shall expire on October 17, 2021, and the warrants issued in its March 2018 Private Placement, May 2018 Private Placement and August 2018 Financing shall expire on September 4, 2023. The exercise price and number of shares of common stock or other securities issuable on exercise of such warrants are subject to customary adjustment in certain circumstances, including in the event of a stock dividend, recapitalization, reorganization, merger or consolidation of the Company. As of September 30, 2020, all placement agent warrants, issued prior to the August 19, 2019 financing had been exercised, and the 20,000 warrants issued in the August 19, 2019 financing are the only placement agent warrants which remain outstanding, which have an exercise price of $10. As of September 30, 2020 and December 31, 2019, 20,000 warrants and 4,576 warrants, respectively, have been issued to the placement agents and are outstanding and are currently exercisable. Class B Warrants The holders of the Class B Warrants did not exercise any of their warrants during the nine months ended September 30, 2020. Class B Warrants have an exercise price of $120.00 per share and shall expire between October 17, 2021 and May 15, 2023. As of September 30, 2020 and December 31, 2019, the Company had 26,550 Class B Warrants issued and outstanding. Series A Warrants and Series B Warrants On January 24, 2019, the Company entered into an exchange agreement with two institutional investors pursuant to which these investors exercised Series A Warrants to purchase 42,412 shares of the Company’s common stock for total cash proceeds of $2,172,680 to the Company, net of costs of $159,958. The two investors also exchanged Series A Warrants to purchase 50,894 shares of its common stock into 50,894 shares of its common stock and received new warrants to purchase an aggregate of 933,056 shares of its common stock. These new warrants have terms substantially similar to the terms of the Company’s Series A Warrants, except that the per share exercise price of the new warrants is $36.70, and the warrants are not exercisable until July 24, 2019, the six-month anniversary of the date of issuance. Each warrant expires on the fifth anniversary of the original issuance date. As of September 30, 2020 and December 31, 2019, the Company had 519,001 Series A Warrants issued and outstanding. 2020 Offering Warrants In the January 28, 2020 public offering, the Company sold 49.45 million warrants (each exercisable into 1/20 of a share of common stock for a total of 2.4725 million shares of common stock).In the June 2, 2020 public offering, the Company sold 20.7 million warrants (each exercisable into 1 share of common stock for a total of 20.7 million shares of common stock.) Each warrant expires on the fifth anniversary of the original issuance date. As of September 30, 2020, the Company had 20,780,115 2020 Offering Warrants issued and outstanding. The 2016 Equity Incentive Plan The 2016 Equity Incentive Plan (the “2016 Plan”) was adopted by the Board of Directors and approved by the shareholders on July 6, 2016. The awards per 2016 Plan may be granted through July 5, 2026 to the Company’s employees, consultants, directors and non-employee directors provided such consultants, directors and non-employee directors render good faith services not in connection with the offer and sale of securities in a capital-raising transaction. The maximum number of shares of our common stock that may be issued under the 2016 Plan is 200,000 shares, which amount will be (a) reduced by awards granted under the 2016 Plan, and (b) increased to the extent that awards granted under the 2016 Plan are forfeited, expire or are settled for cash (except as otherwise provided in the 2016 Plan). No employee will be eligible to receive more than 12,500 shares of common stock in any calendar year under the 2016 Plan pursuant to the grant of awards. On January 3, 2017, the Board of Directors of the Company approved and granted to the President/Chief Executive Officer of the Company, an option to purchase 12,500 shares of the Company’s Common Stock (“Option”) under the Company’s 2016 Plan. The Option will have an exercise price that is no less than $100.00 per share and will vest over four (4) years, with 25% of the total number of shares subject to the Option vesting on the one (1) year anniversary of the date of grant and, the remainder vesting in equal installments on the last day of each of the thirty-six (36) full calendar months thereafter. Vesting will depend on the Officer’s continued service as an employee with the Company and will be subject to the terms and conditions of the 2016 Plan and the written Stock Option Agreement governing the Option. As of December 31, 2018, the Company estimated the fair value of the options using the Black-Scholes option pricing model was $448,861. The Company recorded compensation expense of $28,054 for each of the three months ended September 30, 2020 and 2019, respectively. The Company recorded compensation expense of $84,161 for each of the nine months ended September 30, 2020 and 2019. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $3.060 at the issuance date; a risk-free interest rate of 1.72% and the expected volatility of the Company’s common stock of 315.83% (estimated based on the common stock of comparable public entities). As of September 30, 2020, the unrecognized compensation expense was $28,054 which will be recognized as compensation expense over 0.25 years. The 2018 Equity Incentive Plan Effective July 1, 2018, the Board of Directors and the stockholders of the Company approved and adopted the Company’s 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan supplements, and does not replace, the existing 2016 Equity Incentive Plan. Awards may be granted under the 2018 Plan through June 30, 2023 to the Company’s employees, officers, consultants, and non-employee directors. The maximum number of shares of our common stock that may be issued under the 2018 Plan is 3.5 million (3,500,000) shares, which amount will be (a) reduced by awards granted under the 2018 Plan, and (b) increased to the extent that awards granted under the 2018 Plan are forfeited, expire or are settled for cash (except as otherwise provided in the 2018 Plan). Currently, no employee will be eligible to receive more than 350,000 shares of common stock (10% of authorized shares under the 2018 Plan) in any calendar year under the 2018 Plan pursuant to the grant of awards. When the Board first adopted the 2018 Plan on July 1, 2018, there were 100,000 shares authorized for issuance under the 2018 Plan. On September 12, 2018, the Board of Directors approved to increase the number of shares of common stock reserved for future issuance under the 2018 Plan from 100,000 shares to 200,000 shares. On June 9, 2019, the Board of Directors approved to increase the authorized shares under the 2018 Plan to 2 million (2,000,000) shares. On February 14, 2020, the Board of Directors approved to increase the number of shares of common stock reserved for future issuance under the 2018 plan to 3.5 million (3,500,000) shares. On September 14, 2018, 100,000 shares of common stock underlying awards under the 2018 Plan were granted to the employees and officers, 25% vesting immediately on the date of grant and 25% vesting each year thereafter on the three subsequent anniversaries of the grant date. The Company estimated the fair value of the options using the Black-Scholes option pricing model was $1,241,417. The key valuation assumptions used consist, in part, of the price of the Company’s common stock at $3.90 or $4.29 at the issuance date; a risk-free interest rate ranging of 1.9% and the expected volatility of the Company’s common stock ranging from of 40% (estimated based on the common stock of comparable public entities) On April 4, 2020, the Company granted 90,635 restricted stock units to two officers of the Company. These units have the following vesting term: 33% on January 1, 2021, 34% on January 1, 2022 and 33% on January 1, 2023. The fair value of these units as of granted date was $144,110 based upon the closing price of the Company’s stock. The Company recorded compensation expense of $(36,370) and $68,336 for the three months ended September 30, 2020 and 2019, respectively. The Company recorded compensation expense of $231,512 and $222,089 for the nine months ended September 30, 2020 and 2019, respectively. As of September 30, 2020, the unrecognized compensation expense was $458,853 which will be recognized as compensation expense over 2.28 years.

Revenue Recognition and Reserve

Revenue Recognition and Reserve for Sales Returns and Allowances	9 Months Ended
	Sep. 30, 2020
Revenue from Contract with Customer [Abstract]
Revenue Recognition and Reserve for Sales Returns and Allowances	NOTE 7: REVENUE RECOGNITION AND RESERVE FOR SALES RETURNS AND ALLOWANCES The Company’s contracts with customers only include one performance obligation (i.e., sale of the Company’s products). Revenue is recognized in the gross amount at a point in time when delivery is completed and control of the promised goods is transferred to the customers. Revenue is measured as the amount of consideration the Company expects to be entitled to in exchange for those goods. The Company’s contracts do not involve financing elements as payment terms with customers are less than one year. Further, because revenue is recognized at the point in time goods are sold to customers, there are no contract asset or contract liability balances. The Company does not disclose remaining performance obligations related to contracts with durations of one year or less as allowed by the practical expedient applicable to such contracts. The Company disaggregates its revenues by major geographic region. See Note 8, Concentrations, Geographic Data, and Sales by Major Customers, for further information. The Company accounts for fees paid to Amazon for products sold through its Amazon Stores as operating expense. The Company offers various discounts, pricing concessions, and other allowances to customers, all of which are considered in determining the transaction price. Certain discounts and allowances are fixed and determinable at the time of sale and are recorded at the time of sale as a reduction to revenue. Other discounts and allowances can vary and are determined at management’s discretion (variable consideration). Specifically, the Company occasionally grants discretionary credits to facilitate markdowns and sales of slow-moving merchandise, and consequently accrues an allowance based on historic credits and management estimates. Further, the Company allows sales returns, consequently records a sales return allowance based upon historic return amounts and management estimates. These allowances (variable consideration) are estimated using the expected value method and are recorded at the time of sale as a reduction to revenue. The Company adjusts its estimate of variable consideration at least quarterly or when facts and circumstances used in the estimation process may change. The variable consideration is not constrained as the Company has sufficient history on the related estimates and does not believe there is a risk of significant revenue reversal. The Company also participates in cooperative advertising arrangements with some customers, whereby it allows a discount from invoiced product amounts in exchange for customer purchased advertising that features the Company’s products. Generally, these allowances range from 2% to 5% of gross sales and are generally based upon product purchases or specific advertising campaigns. Such allowances are accrued when the related revenue is recognized. These cooperative advertising arrangements provide a distinct benefit and fair value, and are accounted for as direct selling expenses. Sales commissions are expensed when incurred as the related revenue is recognized at a point in time and therefore, the amortization period is less than one year. As a result, these costs are recorded as direct selling expenses, as incurred. The Company has also elected to adopt the practical expedient related to shipping and handling fees which allows the Company to account for shipping and handling activities that occur after control of the related good transfers as fulfillment activities instead of assessing such activities as performance obligations. Therefore, shipping and handling activities are considered part of the Company’s obligation to transfer the products and therefore are recorded as direct selling expenses, as incurred The Company’s reserve for sales returns and allowances amounted to $13,000 as of September 30, 2020 and December 31, 2019.

Concentrations

Concentrations	9 Months Ended
	Sep. 30, 2020
Risks and Uncertainties [Abstract]
Concentrations	NOTE 8: CONCENTRATIONS Concentration of Purchase Order Financing The Company used a third-party financing company for the quarters ended September 30, 2020 and 2019, respectively, which provided letters of credit to vendors for a fee against the purchase orders received by the Company for sale of products to its customers. The letters of credit were issued to the vendors to manufacture Company’s products pursuant to the purchase orders received by the Company. Concentration of Customers For the three and nine months ended September 30, 2020 and 2019, respectively, the Company had the following concentrations of customers: Percentage of revenues for the Three Months Ended Percentage of revenues for the Nine Months Ended Percentage of accounts receivables as of September 30, September 30, September 30, December 31, 2020 2019 2020 2019 2020 2019 Customer 1 14 % 17 % 16 % 21 % 14 % 7 % Customer 2 5 % 20 % 10 % 33 % 3 % 16 % Customer 3 11 % 14 % 15 % 6 % 4 % 21 % Customer 4 49 % 0 % 30 % 0 % 56 % 0 % Concentration of Suppliers For the three and nine months ended September 30, 2020 and 2019, respectively, the Company had the following concentrations of suppliers: Percentage of purchases for the Percentage of purchases for the Percentage of accounts Three Months Ended Nine Months Ended payable as of September 30, September 30, September 30, December 31, 2020 2019 2020 2019 2020 2019 Supplier 1 30 % 19 % 26 % 17 % 20 % 16 % Supplier 2 13 % 33 % 19 % 19 % 12 % 36 % Supplier 3 13 % 15 % 13 % 17 % 8 % 11 % Supplier 4 12 % 16 % 17 % 20 % 22 % 5 % Supplier 5 4 % 11 % 5 % 10 % 2 % 2 % Supplier 6 18 % 7 % 14 % 10 % 3 % 3 % Concentration of Credit Risk The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. The Company has not experienced any losses in such accounts through September 30, 2020 and 2019. The Company’s bank balances exceeded FDIC insured amounts at times during the three and nine months ended September 30, 2020 and 2019. The Company’s bank balance exceeded the FDIC insured amounts as of September 30, 2020 by approximately $8.4 million. Geographic Concentration For the three and nine months ended September 30, 2020 and 2019, respectively, the Company had the following geographic concentrations: Percentage of revenues for the Percentage of revenues for the Percentage of accounts Three Months Ended Nine Months Ended receivables as of September 30, September 30, September 30, December 31, 2020 2019 2020 2019 2020 2019 Australia 2 % 10 % 3 % 9 % 1 % 7 % Belgium 0 % 0 % 0 % 0 % 0 % 12 % Canada 4 % 6 % 5 % 4 % 3 % 10 % Germany 4 % 1 % 4 % 2 % 4 % 1 % Russia 2 % 3 % 1 % 1 % 0 % 3 % South Korea 0 % 7 % 4 % 7 % 0 % 5 % United Kingdom 3 % 14 % 3 % 10 % 3 % 3 % United States of America 85 % 59 % 80 % 67 % 89 % 59 %

Senior Secured Convertible Note

Senior Secured Convertible Notes	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Senior Secured Convertible Notes	NOTE 9: SENIOR SECURED CONVERTIBLE NOTES On August 19, 2019, the Company entered into a Securities Purchase Agreement with an institutional investor pursuant to which it sold $11.5 million aggregate principal amount of promissory notes (at an aggregate original issue discount of 15%) to the investor in a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended. The first note (the “Series A Note”) has a face amount of $6.72 million for which the investor paid $5 million in cash. The second note (the “Series B Note” and with the Series A Note, collectively referred to as the “Notes”) has a principal amount of $4.78 million for which the investor paid $4.78 million in the form of a full recourse promissory note issued by the investor to the Company (the “Investor Note”) secured by $4.78 million in cash or cash equivalents of the investor (i.e :an original issue discount of approximately 15% to the face amount of the Series B Note). No portion of the Series B Note may be converted into shares of our common stock (the “Common Stock”) until the corresponding portion of the Investor Note has been prepaid to the Company in cash, at which point in time such portion of the Series B Note shall be deemed “unrestricted”. The Investor Note is subject to optional prepayment at any time at the option of the investor and mandatory prepayment, at the Company’s option, subject to certain equity conditions, at any time 45 Trading Days after the effectiveness of a resale registration statement (or otherwise the applicability of Rule 144 promulgated under the Securities Act of 1933, as amended). Notwithstanding the foregoing, the Company may not effect a mandatory prepayment if the shares underlying the Series A Note and the portion of the Series B Note that has become unrestricted exceeds 35% of the market capitalization of the Company. During the nine months ended September 30, 2020, the Company received $3,000,000 in connection with the Investor Note. The Notes are senior secured obligations of the Company secured by a lien on all assets of the Company, bear no interest (unless an event default has occurred and is continuing) and mature on December 31, 2020. The Notes will be convertible at $1.00 into a fixed number of shares (the “Conversion Shares”). The Notes are convertible at the Holder’s option, in whole or in part, at any time after closing. The Conversion Price will be subject to adjustment for stock dividends, stock splits, anti-dilution and other customary adjustment events. The Company shall repay the Principal Amount of the Notes in 12 installments, with the first installment starting on February 1, 2020 (each, an “Installment Date”). Installments 1-3 shall be 1/36th of the Principal Amount, Installments 4-6 shall be 1/18th of the Principal Amount and Installments 7-12 shall be 1/8th of the Principal Amount. The repayment amount shall be payable in cash, or, subject to the satisfaction of equity conditions, at the option of the Company, in registered Common Stock or a combination of cash and registered Common Stock. However, if the 30-day volume weighted average price of the Common Stock (the “VWAP”) of the Company falls below 50% of the market price of a share of the Company’s common stock or the Company fails to satisfy certain other equity conditions, the repayment amount is payable in shares of Common Stock only unless the Investor(s) waive any applicable equity condition. If the Company elects to satisfy all or any portion of an installment in shares of Common Stock, the Company will pre-deliver such shares of Common Stock to the investor on the 23rd trading day prior to the applicable Installment Date, with a true-up of shares (if necessary) on the Installment Date. Any excess shares of Common Stock shall be applied to subsequent installments. The shares used to meet a Principal Repayment (“Installment Shares”) would be valued at a conversion price calculated as the lesser of (i) 85% of the arithmetic average of the three lowest daily VWAPs of the 20 trading days prior to the payment date or (ii) 85% of the VWAP of the trading day prior to payment date (“Installment Price”) with a floor of $0.10. All amortization payments shall be subject to the Investors’ right to (a) defer some or all of any Installment Payment to a subsequent Installment Date; and (b) at any time during an installment period, convert up to four times the installment amount at the Installment Price; provided shares received pursuant to such accelerated conversions shall be subject to a leak-out provision that solely limits sales of such shares received by the investor in such accelerated conversion (and not any other sales) to the greater of (a) $500,000 per trading day or (b) 40% of the volume traded on a given day as reported by Bloomberg LP. Upon completion of a Change of Control, the Holders may require the Company to purchase any outstanding Notes in cash at 125% of par plus accrued but unpaid interest. The Company shall have the right to redeem any and all amounts of the outstanding Note at 125% of the greater of (a) Principal Amount plus accrued but unpaid interest (if any), or (b) Conversion Value plus accrued but unpaid interest (if any) provided the Company has satisfied certain equity conditions. The Company must give the Investor(s) ninety (90) business days’ prior notice of any such redemption. Prior to all outstanding amounts under the Note being repaid in full, the Company will not create any new encumbrances on any of its or its subsidiaries’ assets without the prior written consent of the Lender, with a carve out for a working capital facility of which the details are to be determined. The Notes shall also be subject to standard events of default and remedies therefor. The Company filed a registration statement (“Effectiveness Date”) on Form S-1 (file No: 333-233655) covering the resale of the shares underlying the Series A Note, the Series B Note and Warrants which was declared effective by the SEC on October 15, 2019. In connection with the granting of the Notes, the Company shall issue detachable warrants to the Investor, exercisable in whole or in part at any time during the five years from the date of issuance, in amount equal to 50% of the conversion shares underlying the Notes and have an exercise price of $1.00 per share. To the extent the Company has a change of control or a spinoff, the warrants provide for a put for the warrants to the Company at their Black- Scholes Valuation. The value of the warrants amounted to $575,000 and was recoded as debt discount in the accompanying balance sheet. Until the 3 year anniversary of the maturity date, the investor shall have the right (but not the obligation) to participate in 50% of any subsequent equity or debt issuance. Consummation of the transaction has been subject to certain conditions precedent, including the Company agrees to procure an approval of this transaction at its annual shareholder meeting scheduled no later than 180 days after the Closing Date and agrees to procure voting agreements from principal shareholders prior to closing of the Company. On December 23, 2019, the Company entered into an exchange agreement with an institutional investor pursuant to which the investor is exchanging $5.5 million principal amount of its August 19, 2019 Series A Senior Secured Note for 5,775 shares of its Series D Preferred Stock, which was authorized by the Company’s Board of Directors on December 21, 2019. During the nine months ended September 30, 2020, $3,200,000 principal amount of Notes was converted into Common Stock. As of September 30, 2020, the principal amount of Notes amounted to $2,131,050, net of debt issuance costs of $185,985. As of December 31, 2019, the principal amount of Notes amounted to $5,602,750, net of debt issuance costs of $1,386,443.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2020
Subsequent Events [Abstract]
Subsequent Events	NOTE 6: STOCKHOLDERS’ EQUITY (DEFICIT) At September 30, 2020 and December 31, 2019, the Company had 200,000,000 and 100,000,000 shares of common stock, respectively, and 5,000,000 shares of Series C preferred stock authorized, both with a par value of $0.0001 per share. In addition, as of September 30, 2020, the Company had 5,775 shares of Series D preferred stock, authorized, with a par value of $1,000 per share. Common Stock and Preferred Stock On January 24, 2019, the Company entered into an exchange agreement with two institutional investors pursuant to which these investors exercised Series A Warrants to purchase 424,116 shares of its common stock for cash proceeds of $2,172,680 to the Company, net of costs of $159,958. The two investors also exchanged Series A Warrants to purchase 508,940 shares of its common stock into 508,940 shares of its common stock and received new warrants to purchase an aggregate of 933,056 shares of its common stock. The Company recognized an inducement cost of $0 and $2,137,190 for the Series A Warrants conversion for the nine months ended September 30, 2020 and 2019, respectively, as an offset against stockholders’ equity. The inducement cost was calculated as being the difference between the fair value of equity instruments surrendered versus equity instruments issued pursuant to the terms of the exchange agreement. On February 14, 2019, the Company received cash proceeds of $16,818 from three placement agent warrant holders upon their exercise of 1,402 placement agent warrants to purchase 4,004 Class A Units, each Class A Unit consisting of one share of common stock and a Series A Warrant and a Series B Warrant (“Class A Unit”). Each Series A Warrant is exercisable by the holder thereof for one share of common stock at an exercise price of $36.70 for five years. The Series B Warrants have expired. On February 24, 2020, the Company closed on the public offering of 0.445 million shares of its common stock, for gross proceeds of $912,250 based upon the overallotment option arising from the closing of its January 28, 2020 public offering. In the January 28, 2020 public offering, the Company sold 4.5 million shares of its common stock and 49.45 million warrants (each exercisable into 1/20 of a share of common stock for a total of 2.4725 million shares of common stock) from which it received gross proceeds of $9,472,250. On June 12, 2020, the Company closed on the public offering of 1.7 million shares of its common stock, for gross proceeds of $1,683,000 based upon the overallotment option arising from the closing of its June 2, 2020 public offering. In the June 2, 2020 public offering, the Company sold 19 million shares of its common stock and 20.7 million warrants from which it received gross proceeds of $19,017,000. During the nine months ended September 30, 2020, 1,268 shares of Series C Preferred Stock converted into 126,800 shares of the Company’s common stock and 3,563 shares of Series D Preferred Stock converted into 3,141,426 shares of the Company’s common stock. During the nine months ended September, 30, 2020, $3,200,000 principal amount of Notes was converted into the Company’s common Stock During 2020, the Company granted 360,000 shares of common stock to consultants in consideration for services rendered. As of September 30, 2020 and December 31, 2019, the Company had 38,414,631 and 3,300,015 shares of common stock issued and outstanding, respectively. Warrants Placement Agent Warrants The Company has issued an aggregate of 24,758 warrants to the placement agents to purchase one share of its common stock per warrant at an exercise price of $120 per share for 4,758 warrants and $10 for 20,000 warrants. The warrants issued in its October 2016 Private Placement shall expire on October 17, 2021, and the warrants issued in its March 2018 Private Placement, May 2018 Private Placement and August 2018 Financing shall expire on September 4, 2023. The exercise price and number of shares of common stock or other securities issuable on exercise of such warrants are subject to customary adjustment in certain circumstances, including in the event of a stock dividend, recapitalization, reorganization, merger or consolidation of the Company. As of September 30, 2020, all placement agent warrants, issued prior to the August 19, 2019 financing had been exercised, and the 20,000 warrants issued in the August 19, 2019 financing are the only placement agent warrants which remain outstanding, which have an exercise price of $10. As of September 30, 2020 and December 31, 2019, 20,000 warrants and 4,576 warrants, respectively, have been issued to the placement agents and are outstanding and are currently exercisable. Class B Warrants The holders of the Class B Warrants did not exercise any of their warrants during the nine months ended September 30, 2020. Class B Warrants have an exercise price of $120.00 per share and shall expire between October 17, 2021 and May 15, 2023. As of September 30, 2020 and December 31, 2019, the Company had 26,550 Class B Warrants issued and outstanding. Series A Warrants and Series B Warrants On January 24, 2019, the Company entered into an exchange agreement with two institutional investors pursuant to which these investors exercised Series A Warrants to purchase 42,412 shares of the Company’s common stock for total cash proceeds of $2,172,680 to the Company, net of costs of $159,958. The two investors also exchanged Series A Warrants to purchase 50,894 shares of its common stock into 50,894 shares of its common stock and received new warrants to purchase an aggregate of 933,056 shares of its common stock. These new warrants have terms substantially similar to the terms of the Company’s Series A Warrants, except that the per share exercise price of the new warrants is $36.70, and the warrants are not exercisable until July 24, 2019, the six-month anniversary of the date of issuance. Each warrant expires on the fifth anniversary of the original issuance date. As of September 30, 2020 and December 31, 2019, the Company had 519,001 Series A Warrants issued and outstanding. 2020 Offering Warrants In the January 28, 2020 public offering, the Company sold 49.45 million warrants (each exercisable into 1/20 of a share of common stock for a total of 2.4725 million shares of common stock).In the June 2, 2020 public offering, the Company sold 20.7 million warrants (each exercisable into 1 share of common stock for a total of 20.7 million shares of common stock.) Each warrant expires on the fifth anniversary of the original issuance date. As of September 30, 2020, the Company had 20,780,115 2020 Offering Warrants issued and outstanding. The 2016 Equity Incentive Plan The 2016 Equity Incentive Plan (the “2016 Plan”) was adopted by the Board of Directors and approved by the shareholders on July 6, 2016. The awards per 2016 Plan may be granted through July 5, 2026 to the Company’s employees, consultants, directors and non-employee directors provided such consultants, directors and non-employee directors render good faith services not in connection with the offer and sale of securities in a capital-raising transaction. The maximum number of shares of our common stock that may be issued under the 2016 Plan is 200,000 shares, which amount will be (a) reduced by awards granted under the 2016 Plan, and (b) increased to the extent that awards granted under the 2016 Plan are forfeited, expire or are settled for cash (except as otherwise provided in the 2016 Plan). No employee will be eligible to receive more than 12,500 shares of common stock in any calendar year under the 2016 Plan pursuant to the grant of awards. On January 3, 2017, the Board of Directors of the Company approved and granted to the President/Chief Executive Officer of the Company, an option to purchase 12,500 shares of the Company’s Common Stock (“Option”) under the Company’s 2016 Plan. The Option will have an exercise price that is no less than $100.00 per share and will vest over four (4) years, with 25% of the total number of shares subject to the Option vesting on the one (1) year anniversary of the date of grant and, the remainder vesting in equal installments on the last day of each of the thirty-six (36) full calendar months thereafter. Vesting will depend on the Officer’s continued service as an employee with the Company and will be subject to the terms and conditions of the 2016 Plan and the written Stock Option Agreement governing the Option. As of December 31, 2018, the Company estimated the fair value of the options using the Black-Scholes option pricing model was $448,861. The Company recorded compensation expense of $28,054 for each of the three months ended September 30, 2020 and 2019, respectively. The Company recorded compensation expense of $84,161 for each of the nine months ended September 30, 2020 and 2019. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $3.060 at the issuance date; a risk-free interest rate of 1.72% and the expected volatility of the Company’s common stock of 315.83% (estimated based on the common stock of comparable public entities). As of September 30, 2020, the unrecognized compensation expense was $28,054 which will be recognized as compensation expense over 0.25 years. The 2018 Equity Incentive Plan Effective July 1, 2018, the Board of Directors and the stockholders of the Company approved and adopted the Company’s 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan supplements, and does not replace, the existing 2016 Equity Incentive Plan. Awards may be granted under the 2018 Plan through June 30, 2023 to the Company’s employees, officers, consultants, and non-employee directors. The maximum number of shares of our common stock that may be issued under the 2018 Plan is 3.5 million (3,500,000) shares, which amount will be (a) reduced by awards granted under the 2018 Plan, and (b) increased to the extent that awards granted under the 2018 Plan are forfeited, expire or are settled for cash (except as otherwise provided in the 2018 Plan). Currently, no employee will be eligible to receive more than 350,000 shares of common stock (10% of authorized shares under the 2018 Plan) in any calendar year under the 2018 Plan pursuant to the grant of awards. When the Board first adopted the 2018 Plan on July 1, 2018, there were 100,000 shares authorized for issuance under the 2018 Plan. On September 12, 2018, the Board of Directors approved to increase the number of shares of common stock reserved for future issuance under the 2018 Plan from 100,000 shares to 200,000 shares. On June 9, 2019, the Board of Directors approved to increase the authorized shares under the 2018 Plan to 2 million (2,000,000) shares. On February 14, 2020, the Board of Directors approved to increase the number of shares of common stock reserved for future issuance under the 2018 plan to 3.5 million (3,500,000) shares. On September 14, 2018, 100,000 shares of common stock underlying awards under the 2018 Plan were granted to the employees and officers, 25% vesting immediately on the date of grant and 25% vesting each year thereafter on the three subsequent anniversaries of the grant date. The Company estimated the fair value of the options using the Black-Scholes option pricing model was $1,241,417. The key valuation assumptions used consist, in part, of the price of the Company’s common stock at $3.90 or $4.29 at the issuance date; a risk-free interest rate ranging of 1.9% and the expected volatility of the Company’s common stock ranging from of 40% (estimated based on the common stock of comparable public entities) On April 4, 2020, the Company granted 90,635 restricted stock units to two officers of the Company. These units have the following vesting term: 33% on January 1, 2021, 34% on January 1, 2022 and 33% on January 1, 2023. The fair value of these units as of granted date was $144,110 based upon the closing price of the Company’s stock. The Company recorded compensation expense of $(36,370) and $68,336 for the three months ended September 30, 2020 and 2019, respectively. The Company recorded compensation expense of $231,512 and $222,089 for the nine months ended September 30, 2020 and 2019, respectively. As of September 30, 2020, the unrecognized compensation expense was $458,853 which will be recognized as compensation expense over 2.28 years.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts and factored receivables, valuation of long-lived assets, accrued liabilities, notes payable and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
Cash	Cash The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents. The Company did not have any cash equivalents at September 30, 2020 and December 31, 2019.
Accounts Receivable	Accounts Receivable Accounts receivable represent income earned from the sale of tools and accessories for which the Company has not yet received payment. Accounts receivable are recorded at the invoiced amount and adjusted for amounts management expects to collect from balances outstanding at period-end. The Company estimates the allowance for doubtful accounts based on an analysis of specific accounts and an assessment of the customer’s ability to pay, among other factors. At September 30, 2020 and December 31, 2019, no allowance for doubtful accounts was recorded. The Company accounts for the transfer of accounts receivable to a third party under a factoring type arrangement in accordance with Accounting Standards Codification (“ASC”) 860, “ Transfers and Servicing
Inventory	Inventory Inventory is valued at the lower of cost or net realizable value using the first-in, first-out method. The reported net value of inventory includes finished saleable products that will be sold or used in future periods. The Company reserves for obsolete and slow-moving inventory. At September 30, 2020 and 2019, there were no reserves for obsolete and slow-moving inventory.
Property and Equipment	Property and Equipment Property and equipment are recorded at cost, less accumulated depreciation. The Company provides for depreciation on a straight-line basis over the estimated useful lives of the assets which range from three to seven years. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the related assets when they are placed into service. The Company evaluates property and equipment for impairment periodically to determine if changes in circumstances or the occurrence of events suggest the carrying value of the asset or asset group may not be recoverable. Maintenance and repairs are charged to operations as incurred. Expenditures which substantially increase the useful lives of the related assets are capitalized.
Long-lived Assets	Long-lived Assets In accordance with ASC 360, “ Property, Plant, and Equipment
Fair Value of Financial Instruments and Fair Value Measurements	Fair Value of Financial Instruments and Fair Value Measurements The Company adheres to ASC 820, which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 applies to reported balances that are required or permitted to be measured at fair value under existing accounting pronouncements; accordingly, the standard does not require any new fair value measurements of reported balances. ASC 820 emphasizes that fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). ● Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access. ● Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves that are observable at commonly quoted intervals. ● Level 3 inputs are unobservable inputs for the asset or liability, which is typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. The Company had no instruments requiring such valuation as of September 30, 2020 and December 31, 2019.
Revenue Recognition	Revenue Recognition The Company recognizes revenues when product is delivered to the customer, and the ownership is transferred. The Company’s revenue recognition policy is based on the revenue recognition criteria established under the Financial Accounting Standards Board – Accounting Standards Codification 606 “Revenue From Contracts With Customers
Income Taxes	Income Taxes The Company accounts for income taxes following the asset and liability method in accordance with the ASC 740 “Income Taxes.” Under such method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. The Company applies the accounting guidance issued to address the accounting for uncertain tax positions. This guidance clarifies the accounting for income taxes, by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements as well as provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company classifies interest and penalty expense related to uncertain tax positions as a component of income tax expense. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years that the asset is expected to be recovered or the liability settled. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets depends on the generation of future taxable income during the period in which related temporary differences become deductible. The Company considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in its assessment of a valuation allowance.
Stock Based Compensation	Stock Based Compensation The Company accounts for stock-based compensation in accordance with ASC 718-10, “ Share-Based Payment Compensation – Stock Compensation (Topic 718), Improvements to Nonemployee Share-Based Payment Accounting The Company estimates the fair value of stock options granted using the Black-Scholes option-pricing formula. This fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. The Company’s determination of fair value using an option-pricing model is affected by the stock price as well as assumptions regarding the number of highly subjective variables. The Company estimates volatility based upon the historical stock price of the comparable companies and estimates the expected term for employee stock options using the simplified method for employees and directors and the contractual term. The risk-free rate is determined based upon the prevailing rate of United States Treasury securities with similar maturities. The Company recognizes forfeitures as they occur rather than applying a prospective forfeiture rate in advance.
Earnings (Loss) Per Share	Earnings (Loss) Per Share The Company computes net earnings (loss) per share in accordance with ASC 260, “ Earnings per Share” Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Net income (loss) computation of basic and diluted net loss per common share: Net income (loss) $ 120,835 $ (2,689,342 ) $ (6,152,982 ) $ (2,181,707 ) Less: Redemption of Series D Preferred Stock deemed dividend - - (1,295,294 ) - Less: Common stock deemed dividend (inducement cost) - - - (2,137,190 ) Net income (loss) attributable to common stockholders $ 120,835 $ (2,689,342 ) $ (7,448,276 ) $ (4,318,897 ) Basic and diluted net loss per share: Basic net income (loss) per common share $ 0.00 $ (0.87 ) $ (0.32 ) $ (2.27 ) Basic weighted average common shares outstanding 38,414,631 3,084,456 23,154,481 1,906,179 Diluted net income (loss) per common share $ 0.00 $ (0.87 ) $ (0.32 ) $ (2.27 ) Diluted weighted average common shares outstanding 38,414,631 3,084,456 23,154,481 1,906,179 Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows as of September 30, (in common equivalent shares): 2020 2019 Warrants 21,925,102 1,183,877 Series A & B Notes 213,105 - Options and restricted stock units 197,193 106,538 Total anti-dilutive weighted average shares 22,335,400 1,290,415
No Segment Reporting	No Segment Reporting The Company operates one reportable segment referred to as the tools segment. A single management team that reports to the Chief Executive Officer comprehensively manages the business. Accordingly, the Company does not have separately reportable segments.
Recent Accounting Pronouncements	Recent Accounting Pronouncements As an emerging growth company, the Company has elected to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Securities and Exchange Act of 1934, as amended. In February 2016, the FASB issued ASU 2016-02, “ Leases In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (“Topic 326”)”. The ASU introduces a new accounting model, the Current Expected Credit Losses model (“CECL”), which requires earlier recognition of credit losses and additional disclosures related to credit risk. The CECL model utilizes a lifetime expected credit loss measurement objective for the recognition of credit losses at the time the financial asset is originated or acquired. ASU 2016-13 is effective for annual period beginning after December 15, 2022, including interim reporting periods within those annual reporting periods. The Company is currently evaluating this guidance to determine its impact it may have on its financial statements. In December 2019, the FASB Issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting of Income Taxes,” which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for fiscal years and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating this guidance to determine its impact it may have on its financial statements. In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and simplifies the diluted earnings per share calculation in certain areas. The amendments in this ASU are effective for annual and interim periods beginning after December 15, 2021, although early adoption is permitted. The Company is in the process of evaluating the impact of this new guidance on its financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Schedule of Earning Per Share	Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Net income (loss) computation of basic and diluted net loss per common share: Net income (loss) $ 120,835 $ (2,689,342 ) $ (6,152,982 ) $ (2,181,707 ) Less: Redemption of Series D Preferred Stock deemed dividend - - (1,295,294 ) - Less: Common stock deemed dividend (inducement cost) - - - (2,137,190 ) Net income (loss) attributable to common stockholders $ 120,835 $ (2,689,342 ) $ (7,448,276 ) $ (4,318,897 ) Basic and diluted net loss per share: Basic net income (loss) per common share $ 0.00 $ (0.87 ) $ (0.32 ) $ (2.27 ) Basic weighted average common shares outstanding 38,414,631 3,084,456 23,154,481 1,906,179 Diluted net income (loss) per common share $ 0.00 $ (0.87 ) $ (0.32 ) $ (2.27 ) Diluted weighted average common shares outstanding 38,414,631 3,084,456 23,154,481 1,906,179
Schedule of Potential Dilutive Securities	Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows as of September 30, (in common equivalent shares): 2020 2019 Warrants 21,925,102 1,183,877 Series A & B Notes 213,105 - Options and restricted stock units 197,193 106,538 Total anti-dilutive weighted average shares 22,335,400 1,290,415

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	9 Months Ended
	Sep. 30, 2020
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment consists of the following: September 30, 2020 December 31, 2019 Furniture $ 183,512 $ 111,490 Computers 460,500 254,243 Production equipment 182,446 182,446 Automobile and transportation 412,509 - Tooling and molds 1,515,400 605,485 Website design 477,238 360,943 Leasehold Improvements 42,249 42,249 Less: accumulated depreciation (921,293 ) (526,971 ) Property and Equipment, net $ 2,352,561 $ 1,029,885
Schedule of Depreciation and Capitalized Costs	Depreciation and capitalized costs with respect thereto consists of the following: Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Depreciation expense $ 176,691 $ 55,741 $ 394,322 $ 157,652

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Lease Commitments	Future minimum lease and other commitments of the Company are as follows: For the years ending Slotting Expenses Building leases Total 2020 (remaining) - 121,984 121,984 2021 333,333 502,872 836,205 2022 - 371,077 371,077 2023 - 341,653 341,653 2024 - 358,085 358,085 Thereafter - 89,521 89,521 $ 333,333 $ 1,785,192 $ 2,118,525

Concentrations (Tables)

Concentrations (Tables)	9 Months Ended
	Sep. 30, 2020
Risks and Uncertainties [Abstract]
Schedule of Concentration Risk Percentage	Concentration of Customers For the three and nine months ended September 30, 2020 and 2019, respectively, the Company had the following concentrations of customers: Percentage of revenues for the Three Months Ended Percentage of revenues for the Nine Months Ended Percentage of accounts receivables as of September 30, September 30, September 30, December 31, 2020 2019 2020 2019 2020 2019 Customer 1 14 % 17 % 16 % 21 % 14 % 7 % Customer 2 5 % 20 % 10 % 33 % 3 % 16 % Customer 3 11 % 14 % 15 % 6 % 4 % 21 % Customer 4 49 % 0 % 30 % 0 % 56 % 0 % Concentration of Suppliers For the three and nine months ended September 30, 2020 and 2019, respectively, the Company had the following concentrations of suppliers: Percentage of purchases for the Percentage of purchases for the Percentage of accounts Three Months Ended Nine Months Ended payable as of September 30, September 30, September 30, December 31, 2020 2019 2020 2019 2020 2019 Supplier 1 30 % 19 % 26 % 17 % 20 % 16 % Supplier 2 13 % 33 % 19 % 19 % 12 % 36 % Supplier 3 13 % 15 % 13 % 17 % 8 % 11 % Supplier 4 12 % 16 % 17 % 20 % 22 % 5 % Supplier 5 4 % 11 % 5 % 10 % 2 % 2 % Supplier 6 18 % 7 % 14 % 10 % 3 % 3 %
Schedule of Geographical Distribution of Revenue Percentage	Percentage of revenues for the Percentage of revenues for the Percentage of accounts Three Months Ended Nine Months Ended receivables as of September 30, September 30, September 30, December 31, 2020 2019 2020 2019 2020 2019 Australia 2 % 10 % 3 % 9 % 1 % 7 % Belgium 0 % 0 % 0 % 0 % 0 % 12 % Canada 4 % 6 % 5 % 4 % 3 % 10 % Germany 4 % 1 % 4 % 2 % 4 % 1 % Russia 2 % 3 % 1 % 1 % 0 % 3 % South Korea 0 % 7 % 4 % 7 % 0 % 5 % United Kingdom 3 % 14 % 3 % 10 % 3 % 3 % United States of America 85 % 59 % 80 % 67 % 89 % 59 %

Nature of Operations and Basi_2

Nature of Operations and Basis of Presentation (Details Narrative) - USD ($)	Jun. 12, 2020	Jun. 02, 2020	Apr. 15, 2020	Feb. 24, 2020	Jan. 28, 2020	Sep. 30, 2020	Dec. 31, 2019
Reverse stock split, description			The Company effected a 1-for-10 reverse stock split (the "Reverse Split") of its issued and outstanding common stock. As a result of the Reverse Split, each ten shares of issued and outstanding prior to the Reverse Split were converted into one share of common stock.
Cash						$ 8,891,612	$ 25,063
Public Offering [Member]
Initial public offering, shares	1,700,000			445,000
Number of shares exercisable for warrants					2,472,500
Proceeds from initial public offering	$ 1,683,000			$ 912,250
Stock issued during the period, value					$ 9,472,250
Public Offering [Member] | Common Stock [Member]
Initial public offering, shares		19,000,000			4,500,000
Public Offering [Member] | Warrant [Member]
Initial public offering, shares		20,700,000			49,450,000
Stock issued during the period, value		$ 19,017,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative)	3 Months Ended		9 Months Ended
	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)Segment	Sep. 30, 2019USD ($)	Dec. 31, 2019USD ($)
Cash equivalents
Allowance for doubtful accounts
Allowances for sales discount	13,000		13,000		13,000
Inventory reserves for obsolete
Impairment loss
Number of reportable segment | Segment			1
Minimum [Member]
Estimated useful life of property plant and equipment			3 years
Maximum [Member]
Estimated useful life of property plant and equipment			7 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule of Earning Per Share (Details) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019
Accounting Policies [Abstract]
Net income (loss)	$ 120,835	$ (2,519,158)	$ (3,754,659)	$ (2,689,342)	$ 7,422	$ 500,213	$ (6,152,982)	$ (2,181,707)
Less: Redemption of Series D Preferred Stock deemed dividend							(1,295,294)
Less: Common stock deemed dividend (inducement cost)								(2,137,190)
Net income (loss) attributable to common stockholders	$ 120,835			$ (2,689,342)			$ (7,488,276)	$ (4,318,897)
Basic net income (loss) per common share	$ 0			$ (0.87)			$ (0.32)	$ (2.27)
Basic weighted average common shares outstanding	38,414,631			3,084,456			23,154,481	1,906,179
Diluted net income (loss) per common share	$ 0			$ (0.87)			$ (0.32)	$ (2.27)
Diluted weighted average common shares outstanding	38,414,631			3,084,456			23,154,481	1,906,179

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Schedule of Potential Dilutive Securities (Details) - shares	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Total anti-dilutive weighted average shares	22,335,400	1,290,415
Warrants [Member]
Total anti-dilutive weighted average shares	21,925,102	1,183,877
Series A and Series B Notes [Member]
Total anti-dilutive weighted average shares	213,105
Options and Restricted Stock Units [Member]
Total anti-dilutive weighted average shares	197,193	106,538

Factor Receivables, Letters o_2

Factor Receivables, Letters of Credit Payable and Loan Payable (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Debt Disclosure [Abstract]
Fixed fee description	The Company paid an initial fixed fee of 5% of the cost of products it purchased from the vendor upon opening the LC, and 1% each 30 days thereafter, after the LC is funded by the Factor until such time as the Factor receives the payment from the Company's customers.
Factor receivable allowance	$ 13,000	$ 13,000
Factor receivable	$ 2,107,082	$ 174,042

Property and Equipment, Net - S

Property and Equipment, Net - Schedule of Property and Equipment (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Less: accumulated depreciation	$ (921,293)	$ (526,971)
Property and Equipment, net	2,352,561	1,029,885
Furniture [Member]
Property and Equipment, gross	183,512	111,490
Computers [Member]
Property and Equipment, gross	460,500	254,243
Production Equipment [Member]
Property and Equipment, gross	182,446	182,446
Automobile and Transportation [Member]
Property and Equipment, gross	412,509
Tooling and Molds [Member]
Property and Equipment, gross	1,515,400	605,485
Website Design [Member]
Property and Equipment, gross	477,238	360,943
Leasehold Improvements [Member]
Property and Equipment, gross	$ 42,249	$ 42,249

Property and Equipment, Net -_2

Property and Equipment, Net - Schedule of Depreciation and Capitalized Costs (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 176,691	$ 55,741	$ 394,322	$ 157,652

Commitments and Contingencies_2

Commitments and Contingencies (Details Narrative) - USD ($)

Jul. 02, 2020

Nov. 26, 2019

Jun. 14, 2019

Sep. 14, 2018

Aug. 30, 2018

Apr. 12, 2018

Jan. 03, 2017

Sep. 30, 2020

Sep. 30, 2019

Sep. 30, 2020

Sep. 30, 2019

Apr. 30, 2020

Operating lease term

5 years

Security deposit

$ 29,297

Direct costs estimated percentage

22.54%

Direct cost lease per month

$ 6,201

Lease commenced date

Dec. 1, 2019

Lease due date

Apr. 1, 2020

Base rent amount

$ 25,200

Expected rent on december 1, 2023

29,480

Initial rent paid

$ 68,128

Other commitments as slotting allowance

Slotting allowance of $1,000,000 payable in three annual installments of $333,334 on March 1, 2019, $333,333 on March 1, 2020 and $333,333 on March 1, 2021.

Slotting allowance, due

$ 1,000,000

Slotting allowance, 2019

333,334

Slotting allowance, 2020

333,333

Slotting allowance, 2021

$ 333,333

Operating lease rental expense

$ 208,672

$ 50,110

536,566

$ 133,762

Slotting expense

83,334

83,334

250,002

250,002

Litigation expense

$ 124,245

$ 65,803

$ 299,869

$ 136,024

American Arbitration Association [Member]

Loss contingency, damages sought, value

$ 169,094

American Arbitration Association [Member] | Cross-Demand [Member]

Loss contingency, damages sought, value

$ 394,956

Chief Financial Officer [Member]

Annual base salary

$ 230,000

Edwin Minassian [Member]

Loss contingency, damages sought, value

$ 7,080

Loss contingency, damages awarded, value

$ 235,542

Ownership percentage

7.00%

Litigation expense

$ 252,949

Number of shares issued during period

376,367

Employment Agreement [Member] | President/Chief Executive Officer [Member]

Term of agreement

5 years

Sign-on-bonus

$ 50,000

Annual base salary

$ 350,000

Increase percentage of base salary

10.00%

Stock option to purchase shares of common stock

125,000

Stock option exercise price per share

$ 10

Employment Agreement [Member] | Vice-President of Design and Development [Member]

Term of agreement

5 years

Sign-on-bonus

$ 35,000

Annual base salary

$ 250,000

Increase percentage of base salary

10.00%

Employment Agreement [Member] | Chief Operating Officer and Secretary [Member]

Term of agreement

3 years

Annual base salary

$ 180,000

Increase percentage of base salary

10.00%

Verbal Consulting Arrangement [Member] | Chief Financial Officer [Member]

Annual base salary

$ 10,000

Commitments and Contingencies -

Commitments and Contingencies - Schedule of Future Minimum Lease Commitments (Details)	Sep. 30, 2020USD ($)
2020 (remaining)	$ 121,984
2021	836,205
2022	371,077
2023	341,653
2024	358,085
Thereafter	89,521
Total	2,118,525
Slotting Expenses [Member]
2020 (remaining)
2021	333,333
2022
2023
2024
Thereafter
Total	333,333
Building Leases [Member]
2020 (remaining)	121,984
2021	502,872
2022	371,077
2023	341,653
2024	358,085
Thereafter	89,521
Total	$ 1,785,192

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) (Details Narrative) - USD ($)	Jun. 12, 2020	Jun. 02, 2020	Apr. 04, 2020	Feb. 24, 2020	Jan. 28, 2020	Feb. 14, 2019	Jan. 24, 2019	Sep. 14, 2018	Jul. 02, 2018	Jan. 03, 2017	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 21, 2019	Aug. 19, 2019	Jun. 09, 2019	Dec. 31, 2018	Sep. 12, 2018
Common stock, shares authorized											200,000,000				200,000,000			200,000,000
Common stock par value											$ 0.0001				$ 0.0001			$ 0.0001
Proceeds from warrants exercise																$ 2,172,680
Common stock, shares issued											38,414,631				38,414,631			3,300,015
Common stock, shares outstanding											38,414,631				38,414,631			3,300,015
Compensation expense															$ 315,673	273,200
2018 Equity Incentive Plan [Member]
Fair value of options																						$ 448,861
Compensation expense											$ (36,370)			$ 68,336	$ 231,512	222,089
Risk-free interest rate															1.90%
Volatility rate															40.00%
Unrecognized compensation expense											$ 458,853				$ 458,853
Compensation expense recognition period															2 years 3 months 11 days
2018 Equity Incentive Plan [Member] | Restricted Stock Unit [Member]
Number of options to purchase common stock			144,110
2018 Equity Incentive Plan [Member] | Restricted Stock Unit [Member] | January 1, 2021 [Member]
Restricted stock units vesting term percentage			33.00%
2018 Equity Incentive Plan [Member] | Restricted Stock Unit [Member] | January 1, 2022 [Member]
Restricted stock units vesting term percentage			34.00%
2018 Equity Incentive Plan [Member] | Restricted Stock Unit [Member] | January 1, 2023 [Member]
Restricted stock units vesting term percentage			33.00%
2018 Equity Incentive Plan [Member] | Maximum [Member]
Share price											$ 4.29				$ 4.29
2018 Equity Incentive Plan [Member] | Minimum [Member]
Share price											3.90				$ 3.90
Public Offering [Member]
Initial public offering, shares	1,700,000			445,000
Proceeds from initial public offering	$ 1,683,000			$ 912,250
Number of shares exercisable for warrants					2,472,500
Stock issued during the period, value					$ 9,472,250
Series A Warrants [Member]
Inducement cost															$ 0	2,137,190
Exercise price of warrants											$ 36.70				$ 36.70
Number of warrants issued											519,001				519,001			519,001
Number of warrants outstanding											519,001				519,001			519,001
Common Stock [Member]
Conversion of common stock, shares													126,800	100,000
Debt conversion, converted instrument, shares issued															3,200,000
Stock issued during period for services, shares												360,000
Common Stock [Member] | Public Offering [Member]
Initial public offering, shares		19,000,000			4,500,000
Warrant [Member] | Public Offering [Member]
Initial public offering, shares		20,700,000			49,450,000
Stock issued during the period, value		$ 19,017,000
Common Stock [Member]
Debt conversion, converted instrument, shares issued															3,200,000
Placement Agent Warrants [Member]
Exercise price of warrants																				$ 10
Number of warrants issued											24,758				24,758					20,000
Number of warrants outstanding											20,000				20,000			4,576
Placement Agent Warrants [Member] | October 2016 Private Placement [Member]
Warrants expiration date											Oct. 17, 2021				Oct. 17, 2021
Placement Agent Warrants [Member] | March 2018 Private Placement [Member]
Warrants expiration date											Sep. 4, 2023				Sep. 4, 2023
Placement Agent Warrants [Member] | May 2018 Private Placement [Member]
Warrants expiration date											Sep. 4, 2023				Sep. 4, 2023
Placement Agent Warrants [Member] | August 2018 Financing [Member]
Warrants expiration date											Sep. 4, 2023				Sep. 4, 2023
Placement Agent Warrants One [Member]
Exercise price of warrants											$ 120				$ 120
Number of warrants issued											4,758				4,758
Placement Agent Warrants Two [Member]
Exercise price of warrants											$ 10				$ 10
Number of warrants issued											20,000				20,000
Class B Warrants [Member]
Exercise price of warrants											$ 120				$ 120
Number of warrants issued											26,550				26,550			265,500
Number of warrants outstanding											26,550				26,550			265,500
Warrants expiration date, description															Expire between October 17, 2021 and May 15, 2023.
Series A Warrant [Member]
Warrants exercisable shares, description															Each warrant expires on the fifth anniversary of the original issuance date.
2020 Offering Warrants [Member]
Number of warrants issued											20,780,115				20,780,115
Number of warrants outstanding											20,780,115				20,780,115
Number of warrants sold		20,700,000			49,450,000
Warrants exercisable shares, description		The Company sold 20.7 million warrants (each exercisable into 1 share of common stock for a total of 20.7 million shares of common stock.)			The Company sold 49.45 million warrants (each exercisable into 1/20 of a share of common stock for a total of 2.4725 million shares of common stock)
Three Placement Agent [Member]
Warrants to purchase common stock						1,402
Proceeds from warrants exercise						$ 16,818
Exercise price of warrants						$ 36.70
Three Placement Agent [Member] | Class A Units [Member]
Number of shares issued for exercise of warrants						4,004
Term of warrants						5 years
Consultant [Member] | Forecast [Member]
Stock issued during period for services, shares																	360,000
Board of Directors [Member] | 2016 Equity Incentive Plan [Member]
Maximum number of shares eligible to receive by employees															12,500
Number of options to purchase common stock										12,500
Exercise price of options										$ 100
Options vesting term										4 years
Percentage of vesting of options										25.00%
Compensation expense											$ 28,054			$ 28,054	$ 84,161	$ 84,161
Share price											$ 3.060				$ 3.060
Risk-free interest rate															1.72%
Volatility rate															315.83%
Unrecognized compensation expense											$ 28,054				$ 28,054
Compensation expense recognition period															3 months
Board of Directors [Member] | 2016 Equity Incentive Plan [Member] | Maximum [Member]
Initial public offering, shares															200,000
Board of Directors [Member] | 2018 Equity Incentive Plan [Member]
Eligible to receive common stock shares description									No employee will be eligible to receive more than 350,000 shares of common stock (10% of authorized shares under the 2018 Plan) in any calendar year under the 2018 Plan pursuant to the grant of awards.
Common stock reserved for future issuance									100,000
Board of Directors [Member] | 2018 Equity Incentive Plan [Member] | Maximum [Member]
Initial public offering, shares									3,500,000
Number of shares employee eligible to receive									350,000
Percentage of shares employee eligible to receive									10.00%
Common stock reserved for future issuance																					2,000,000		200,000
Board of Directors [Member] | 2018 Equity Incentive Plan [Member] | Minimum [Member]
Common stock reserved for future issuance																							100,000
Employees and Officers [Member] | 2018 Equity Incentive Plan [Member]
Number of options to purchase common stock								100,000
Percentage of vesting of options								25.00%
Fair value of options								$ 1,241,417
Employees and Officers [Member] | Anniversaries of the Grant Date [Member] | 2018 Equity Incentive Plan [Member]
Percentage of vesting of options								25.00%
Two Officers [Member] | 2018 Equity Incentive Plan [Member] | Restricted Stock Unit [Member]
Number of restricted stock units granted			90,635
Exchange Agreement [Member] | Investors [Member] | Series A Warrants One [Member]
Warrants to purchase common stock							424,116
Proceeds from warrants exercise							$ 2,172,680
Stock issuance cost							$ 159,958
Exchange Agreement [Member] | Investors [Member] | Series A Warrants Two [Member]
Warrants to purchase common stock							508,940
Number of shares issued for exercise of warrants							508,940
Exchange Agreement [Member] | Investors [Member] | Series A Warrants Three [Member]
Warrants to purchase common stock							933,056
Exchange Agreement [Member] | Investors [Member] | Series A Warrants and Series B Warrants [Member]
Warrants to purchase common stock							42,412
Proceeds from warrants exercise							$ 2,172,680
Stock issuance cost							$ 159,958
Exchange Agreement [Member] | Investors [Member] | Series A Warrants and Series B Warrants One [Member]
Warrants to purchase common stock							50,894
Number of shares issued for exercise of warrants							50,894
Series C Preferred Stock [Member]
Preferred stock, shares authorized											5,000,000				5,000,000			5,000,000
Preferred stock par value											$ 0.0001				$ 0.0001			$ 0.0001
Conversion of common stock, shares													(1,268)
Stock issued during period for services, shares
Series D Preferred Stock [Member]
Preferred stock, shares authorized											5,775				5,775			5,775
Preferred stock par value											$ 1,000				$ 1,000			$ 1,000
Conversion of common stock, shares
Stock issued during period for services, shares
Series D Preferred Stock [Member] | Board of Directors [Member]
Preferred stock, shares authorized																			5,775
Series C Preferred Stock [Member] | Common Stock [Member]
Conversion of common stock, shares															1,268
Initial public offering, shares															126,800
Series D Preferred Stock [Member] | Common Stock [Member]
Conversion of common stock, shares															3,563
Initial public offering, shares															3,141,426

Revenue Recognition and Reser_2

Revenue Recognition and Reserve for Sales Returns and Allowances (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Revenue recognition reserve for sales returns and allowances	$ 13,000	$ 13,000
Minimum [Member] | Revenue [Member]
Concentration risk, percentage	2.00%
Maximum [Member] | Revenue [Member]
Concentration risk, percentage	5.00%

Concentrations (Details Narrati

Concentrations (Details Narrative)	Sep. 30, 2020USD ($)
Risks and Uncertainties [Abstract]
FDIC insured amounts	$ 8,400,000

Concentrations - Schedule of Co

Concentrations - Schedule of Concentration Risk Percentage (Details)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Revenue [Member] | Customer One [Member]
Concentration risk, percentage	14.00%	17.00%	16.00%	21.00%
Revenue [Member] | Customer Two [Member]
Concentration risk, percentage	5.00%	20.00%	10.00%	33.00%
Revenue [Member] | Customer Three [Member]
Concentration risk, percentage	11.00%	14.00%	15.00%	6.00%
Revenue [Member] | Customer Four [Member]
Concentration risk, percentage	49.00%	0.00%	30.00%	0.00%
Accounts Receivable [Member] | Customer One [Member]
Concentration risk, percentage			14.00%		7.00%
Accounts Receivable [Member] | Customer Two [Member]
Concentration risk, percentage			3.00%		16.00%
Accounts Receivable [Member] | Customer Three [Member]
Concentration risk, percentage			4.00%		21.00%
Accounts Receivable [Member] | Customer Four [Member]
Concentration risk, percentage			56.00%		0.00%
Purchase [Member] | Supplier One [Member]
Concentration risk, percentage	30.00%	19.00%	26.00%	17.00%
Purchase [Member] | Supplier Two [Member]
Concentration risk, percentage	13.00%	33.00%	19.00%	19.00%
Purchase [Member] | Supplier Three [Member]
Concentration risk, percentage	13.00%	15.00%	13.00%	17.00%
Purchase [Member] | Supplier Four [Member]
Concentration risk, percentage	12.00%	16.00%	17.00%	20.00%
Purchase [Member] | Supplier Five [Member]
Concentration risk, percentage	4.00%	11.00%	5.00%	10.00%
Purchase [Member] | Supplier Six [Member]
Concentration risk, percentage	18.00%	7.00%	14.00%	10.00%
Accounts Payable [Member] | Supplier One [Member]
Concentration risk, percentage			20.00%		16.00%
Accounts Payable [Member] | Supplier Two [Member]
Concentration risk, percentage			12.00%		36.00%
Accounts Payable [Member] | Supplier Three [Member]
Concentration risk, percentage			8.00%		11.00%
Accounts Payable [Member] | Supplier Four [Member]
Concentration risk, percentage			22.00%		5.00%
Accounts Payable [Member] | Supplier Five [Member]
Concentration risk, percentage			2.00%		2.00%
Accounts Payable [Member] | Supplier Six [Member]
Concentration risk, percentage			3.00%		3.00%

Concentrations - Schedule of Ge

Concentrations - Schedule of Geographical Distribution of Revenue Percentage (Details)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Australia [Member] | Revenue [Member]
Concentration risk, percentage	2.00%	10.00%	3.00%	9.00%
Australia [Member] | Accounts Receivable [Member]
Concentration risk, percentage			1.00%		7.00%
Belgium [Member] | Revenue [Member]
Concentration risk, percentage	0.00%	0.00%	0.00%	0.00%
Belgium [Member] | Accounts Receivable [Member]
Concentration risk, percentage			0.00%		12.00%
Canada [Member] | Revenue [Member]
Concentration risk, percentage	4.00%	6.00%	5.00%	4.00%
Canada [Member] | Accounts Receivable [Member]
Concentration risk, percentage			3.00%		10.00%
Germany [Member] | Revenue [Member]
Concentration risk, percentage	4.00%	1.00%	4.00%	2.00%
Germany [Member] | Accounts Receivable [Member]
Concentration risk, percentage			4.00%		1.00%
Russia [Member] | Revenue [Member]
Concentration risk, percentage	2.00%	3.00%	1.00%	1.00%
Russia [Member] | Accounts Receivable [Member]
Concentration risk, percentage			0.00%		3.00%
South Korea [Member] | Revenue [Member]
Concentration risk, percentage	0.00%	7.00%	4.00%	7.00%
South Korea [Member] | Accounts Receivable [Member]
Concentration risk, percentage			0.00%		5.00%
United Kingdom [Member] | Revenue [Member]
Concentration risk, percentage	3.00%	14.00%	3.00%	10.00%
United Kingdom [Member] | Accounts Receivable [Member]
Concentration risk, percentage			3.00%		3.00%
United States of America [Member] | Revenue [Member]
Concentration risk, percentage	85.00%	59.00%	80.00%	67.00%
United States of America [Member] | Accounts Receivable [Member]
Concentration risk, percentage			89.00%		59.00%

Senior Secured Convertible No_2

Senior Secured Convertible Notes (Details Narrative)	Aug. 19, 2019USD ($)Founder$ / shares	Sep. 30, 2020USD ($)shares	Sep. 30, 2019USD ($)	Dec. 31, 2019USD ($)shares	Dec. 23, 2019USD ($)	Dec. 21, 2019shares
Cash proceeds on the promissory note			$ 4,515,000
Principal amount		2,131,050		$ 5,602,750
Debt issuance cost net		$ 185,985		$ 1,386,443
Promissory note payable date	Dec. 31, 2020
Debt instrument conversion price | $ / shares	$ 1
Debt installment, description	The Company shall repay the Principal Amount of the Notes in 12 installments, with the first installment starting on February 1, 2020 (each, an "Installment Date"). Installments 1-3 shall be 1/36th of the Principal Amount, Installments 4-6 shall be 1/18th of the Principal Amount and Installments 7-12 shall be 1/8th of the Principal Amount. The repayment amount shall be payable in cash, or, subject to the satisfaction of equity conditions, at the option of the Company, in registered Common Stock or a combination of cash and registered Common Stock.
Debt market price rate	50.00%
Conversion price, description	The shares used to meet a Principal Repayment ("Installment Shares") would be valued at a conversion Price, calculated as the lesser of (i) 85% of the arithmetic average of the three lowest daily VWAPs of the 20 trading days prior to the payment date or (ii) 85% of the VWAP of the trading day prior to payment date ("Installment Price") with a floor of $0.10.
Debt instrument trading days | Founder	20
Debt instrument, convertible percentage	85.00%
Percentage to purchase outstanding notes in cash	125.00%
Debt issuance, description	Until the 3 year anniversary of the maturity date, the investor shall have the right (but not the obligation) to participate in 50% of any subsequent equity or debt issuance.	As of September 30, 2020, the principal amount of Notes amounted to $2,131,050, net of debt issuance costs of $185,985. As of December 31, 2019, the principal amount of Notes amounted to $5,602,750, net of debt issuance costs of $1,386,443.
Common Stock [Member]
Debt conversion, converted instrument, shares issued | shares		3,200,000
Institutional Investor [Member] | Securities Purchase Agreement [Member]
Cash proceeds on the promissory note	$ 11,500,000
Original issue discount, percentage	15.00%
Description for market capitalization	The Investor Note is subject to optional prepayment at any time at the option of the investor and mandatory prepayment, at the Company's option, subject to certain equity conditions, at any time 45 Trading Days after the effectiveness of a resale registration statement (or otherwise the applicability of Rule 144 promulgated under the Securities Act of 1933, as amended). Notwithstanding the foregoing, the Company may not effect a mandatory prepayment if the shares underlying the Series A Note and the portion of the Series B Note that has become unrestricted exceeds 35% of the market capitalization of the Company.
Investor [Member]
Debt instrument conversion price | $ / shares	$ 500,000
Debt installment, description	All amortization payments shall be subject to the Investors' right to (a) defer some or all of any Installment Payment to a subsequent Installment Date; and (b) at any time during an installment period, convert up to four times the installment amount at the Installment Price; provided shares received pursuant to such accelerated conversions shall be subject to a leak-out provision that solely limits sales of such shares received by the investor in such accelerated conversion (and not any other sales) to the greater of (a) $500,000 per trading day or (b) 40% of the volume traded on a given day as reported by Bloomberg LP.
Debt market price rate	40.00%
Warrants term	5 years
Warrants conversion price percentage	50.00%
Warrants exercise price | $ / shares	$ 1
Fair value of warrant liability	$ 575,000
Investor [Member] | Exchange Agreement [Member]
Promissory note face amount					$ 5,500,000
Series D Preferred Stock [Member]
Preferred stock, shares authorized | shares		5,775		5,775
Series D Preferred Stock [Member] | Board of Directors [Member]
Preferred stock, shares authorized | shares						5,775
Series A Note [Member] | Investor [Member]
Promissory note face amount	6,720,000
Payment of promissory note	$ 5,000,000
Notes [Member] | Investor [Member]
Original issue discount, percentage	15.00%
Promissory note face amount	$ 4,780,000
Payment of promissory note	$ 4,780,000
Company received amount in connection with note		$ 3,000,000